EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

List of PDF Full Texts available from EurekaMag Chapter 67457

Chapter 67457 contains a list of PDF Full Texts available from EurekaMag.




P17.44 * the effect of a Surgery Rationale on Life Expectancy within Primary Glioblastoma Multiforme Patients: Resection Compare to Sole Biopsy. Six and Half Year Regular Follow-Up Experiences of one Onco-Centredatabase of Intracranial Tumours (Doit) of Czech Republic
, Neuro-Oncology 16(Suppl 2): ii 97 (2014)

P17.45 * Carboplatin Alone And In Combination With Bevacizumab In A 5Mg/Kg Every-3-Week Schedule, In Patients With Recurrent Glioblastomas: A Single Center Experience
, Neuro-Oncology 16(Suppl 2): ii 97 (2014)

P17.46 * Late Pseudoprogression in Glioblastoma Patients: Comparable Analysis with Real Tumor Progression
, Neuro-Oncology 16(Suppl 2): ii 98 (2014)

P17.47 * Comprehensive Proteomic Profiling of Bevacizumab-Resistant Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 2): ii 98 (2014)

P17.48 * Survival Benefit of Levetiracetam in Glioblastoma: A Prospective Single-Center Study
, Neuro-Oncology 16(Suppl 2): ii 98 (2014)

P17.49 * Treatment Strategy for Who Grade Iii Gliomas: The Lessons Learned from the Retrospective Multicenter Analysis of 243 Patients
, Neuro-Oncology 16(Suppl 2): ii 98-ii 99 (2014)

P17.50 * Phase Ii Study of Arsenic Trioxide and Temozolomide in Combination with Radiation Therapy in Patients with Malignant Gliomas
, Neuro-Oncology 16(Suppl 2): ii 99 (2014)

O5.07 * the Impact of Neuronavigation and Intraoperative High-Field Mri on Surgery of Gangliogliomas in Patients with Drug Resistant Epilepsy
, Neuro-Oncology 16(Suppl 2): ii 11 (2014 )

P17.51 * Functional Prediction of Mitochondrial DNA Mutations in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 2): ii 99 (2014)

P17.52 * Analysis of Risk and Prognosis Factors in Glioblastoma - Our Experience in 104 Patients
, Neuro-Oncology 16(Suppl 2): ii 99 (2014)

P17.53 * the Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: Our Experience
, Neuro-Oncology 16(Suppl 2): ii 99-ii 100 (2014)

P17.54 * Novel Proteins Associated with Invadopodia Structures in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 2): ii 100 (2014)

P17.55 * Unravelling Grade 3 Gliomas
, Neuro-Oncology 16(Suppl 2): ii 100 (2014)

P17.56 * a 3-Dimensional Matrix Assay to Help Predict Treatment Response to Temozolomide in Patients with Gliobastoma: Update of Results and Subgroup Analysis of Patients Undergoing Mgmt Testing
, Neuro-Oncology 16(Suppl 2): ii 100 (2014)

P17.57 * Combined Chemoradiation in Elderly Patients with Glioblastoma: Comparison of two Radiation Schedules
, Neuro-Oncology 16(Suppl 2): ii 100 (2014)

P17.58 * Detection of Human Papilloma Virus DNA in a Subset of Glioblastoma Samples
, Neuro-Oncology 16(Suppl 2): ii 101 (2014)

P17.59 * Transplanted Mgmtp140K Gene-Modified Cd34+ Cells In Patients With Newly Diagnosed Glioblastoma Chemo-Protect Bone Marrow And Lead To Prolonged Survival
, Neuro-Oncology 16(Suppl 2): ii 101 (2014)

P17.60 * Novo-Ttf 100A System Used Successfully In A Patient With A Ventriculo-Peritoneal Shunt
, Neuro-Oncology 16(Suppl 2): ii 101 (2014)

O5.08 * Intra-Operative Neurophysiological Monitoring and small Craniotomies: Results in a Consecutive Series of 85 Patients with Brain Tumors
, Neuro-Oncology 16(Suppl 2): ii 11 (2014)

P17.61 * Anti-Tumor effects of S14161 in Glioblastoma cells
, Neuro-Oncology 16(Suppl 2): ii 101 (2014)

P17.62 * the Importance of Delayed Pseudoprogression and the Problem with Rano in Gbm
, Neuro-Oncology 16(Suppl 2): ii 101-ii 102 (2014)

P17.63 * Combination Therapy with Temozolomide, Interferon-Beta, and Ribavirin in Glioma cell Lines
, Neuro-Oncology 16(Suppl 2): ii 102 (2014)

P17.64 * Angiogenic and Procoagulant Factors in Plasma of Brain Tumour Patients Treated with Bevacizumab
, Neuro-Oncology 16(Suppl 2): ii 102 (2014)

P17.65 * Radio-Chemotherapy with Temozolomide in Elderly Patients with Glioblastoma. A Mono-Institutional Experience
, Neuro-Oncology 16(Suppl 2): ii 102 (2014)

P17.67 * Subcutaneous Metastases from a Glioblastoma Multiforme: Case Report and Review of Literature
, Neuro-Oncology 16(Suppl 2): ii 103 (2014)

P17.68 * Characterisation of a Novel Aspirin Analogue in Malignant Glioma
, Neuro-Oncology 16(Suppl 2): ii 103 (2014)

P17.69 * Fotemustine Tratment: What about Glioblastoma Patients' Quality of Life?
, Neuro-Oncology 16(Suppl 2): ii 103 (2014)

P17.70 * can Elderly Patients with Glioblastoma Benefit from Conventional Chemo-Radiotherapy Treatment?
, Neuro-Oncology 16(Suppl 2): ii 103-ii 104 (2014)

O1.04 * Role of Aquaporin4 in Human Brain Metastases: Study of 60 Cases
, Neuro-Oncology 16(Suppl 2): ii 1-ii 2 (2014)

O5.09 * Ventricular high Grade Glioma: Neuroendoscopy and Adjuvant Therapy
, Neuro-Oncology 16(Suppl 2): ii 11 (2014)

P17.71 * Role of Atrx and Tert Expression as Diagnostic and Prognostic Factors on Anaplastic Gliomas
, Neuro-Oncology 16(Suppl 2): ii 104 (2014)

P17.72 * Acute Lymphoblastic Leukemia after Temozolomide Treatment for Oligodendroglioma: Case Report
, Neuro-Oncology 16(Suppl 2): ii 104 (2014)

P17.73 * in Vitro Analysis of Cytotoxic effects of Brivaracetam and Lacosamide on Human Glioblastoma cells
, Neuro-Oncology 16(Suppl 2): ii 104 (2014)

P17.74 * Monofocal Lesion of Demyelinating Disease and Differential Diagnosis with high Grade Glioma - Case Report
, Neuro-Oncology 16(Suppl 2): ii 105 (2014)

P17.75 * Utility Of 3D Surgical Planning For Resection Of High-Grade Gliomas
, Neuro-Oncology 16(Suppl 2): ii 105 (2014)

P17.76 * Low-Dose Rate Stereotactic Iodine-125 Brachytherapy for the Treatment of Inoperable Primary and Recurrent Glioblastoma: Single-Center Experience with 201 Cases
, Neuro-Oncology 16(Suppl 2): ii 105 (2014)

P17.78 * Secondary Glioblastoma - Outcome and Prognostic Factors
, Neuro-Oncology 16(Suppl 2): ii 105-ii 106 (2014)

P17.79 * A Melanoma-Astrocytoma Syndrome Associated To A Constitutive Microduplication On 5P15.33, Containing The Tert Gene
, Neuro-Oncology 16(Suppl 2): ii 106 (2014)

P17.80 * Anaplastic Glioma: An Update on Treatment Strategies
, Neuro-Oncology 16(Suppl 2): ii 106 (2014)

P17.81 * Treatment and Survival of Elderly Glioblastoma Patients in Slovenia 1999 - 2013
, Neuro-Oncology 16(Suppl 2): ii 106 (2014)

P17.82 * Itga6 is Involved in Radioresistance of Glioblastoma Stem cells
, Neuro-Oncology 16(Suppl 2): ii 106-ii 107 (2014)

P17.83 * Outcomes of Recurrent Glioblastoma Patients Treated with Bevacizumab at a Tertiary Care Center
, Neuro-Oncology 16(Suppl 2): ii 107 (2014)

P17.84 * Cancer Proteomics and Systems Biology for Personalized Medicine
, Neuro-Oncology 16(Suppl 2): ii 107 (2014)

P17.85 * low Levels of Human Cytomegalovirus Infection in Glioblastoma Multiforme Associates with Patient Survival; a Prospective Study
, Neuro-Oncology 16(Suppl 2): ii 107 (2014)

P17.86 * Identification of Regulated Genes in Glioma-Associated Microglia/Macrophages using Microarray
, Neuro-Oncology 16(Suppl 2): ii 107-ii 108 (2014)

P17.88 * the Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma: Single Center Experience
, Neuro-Oncology 16(Suppl 2): ii 108 (2014)

P17.89 * effects of Glioblastoma First-Line Trials on Time Delay to Initiation of Treatment, Signs of Early Tumor Progression and Progression-Free Survival
, Neuro-Oncology 16(Suppl 2): ii 108 (2014)

P17.90 * Estrogen Receptor Expression in Glioblastoma Influences Pfs and Life Expectancy of Patients
, Neuro-Oncology 16(Suppl 2): ii 108-ii 109 (2014)

O6.01 * Targeting the Immune Checkpoint Network with Mir-138 Exerts Therapeutic Efficacy in Murine Models of Glioma
, Neuro-Oncology 16(Suppl 2): ii 12 (2014)

P17.91 * Clinical Variables Serve as Predictive Factors in a Model for Clinical Response to Bevacizumab in Recurrent Glioblastoma Multiforme: An Observational Study of a Cohort of Consecutive Non-Selected Patients from a Single Institution
, Neuro-Oncology 16(Suppl 2): ii 109 (2014)

P17.92 * Glioblastoma in Elderly Patients: Survival Outcome
, Neuro-Oncology 16(Suppl 2): ii 109 (2014)

P17.93 * Third Line Chemotherapy in high Grade Gliomas: There is a Benefit?
, Neuro-Oncology 16(Suppl 2): ii 109 (2014)

P17.94 * Glioma Gwas Hits - Markers for Risk or for Prognosis?
, Neuro-Oncology 16(Suppl 2): ii 109-ii 110 (2014)

P17.95 * Novottf-100A Alternating Electric Fields Therapy For Recurrent Glioblastoma: An Analysis Of Patient Registry Data
, Neuro-Oncology 16(Suppl 2): ii 110 (2014)

P18.01 * Complementary Therapy Use in a Cohort of Swiss Glioma Patients
, Neuro-Oncology 16(Suppl 2): ii 110 (2014)

P18.02 * a Comparison of the effects of Attention Deficit on Rehabilitation Functional Outcomes in Brain Tumor Patients and Subacute Stroke Patients
, Neuro-Oncology 16(Suppl 2): ii 110 (2014)

P18.03 * Patient Feedback Interviews for Development of Discharge Procedures
, Neuro-Oncology 16(Suppl 2): ii 110-ii 111 ( 2014)

P18.04 * Clinical Progress and Survival of Patients with Glioblastoma after Hypo-Fractionated Radiotherapy
, Neuro-Oncology 16(Suppl 2): ii 111 (2014)

P18.05 * Treatment of Acute Ischemic Stroke in Cancer Patients
, Neuro-Oncology 16(Suppl 2): ii 111 (2014)

O6.02 * Analysis of Pd1 and Pd-L1 Expression in Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 12 (2014)

P18.06 * Zonisamide as Add-On Antiepileptic Drug in Patients with Brain Tumor-Related Epilepsy: Preliminary Data of a Pilot Study
, Neuro-Oncology 16(Suppl 2): ii 111 (2014)

P18.07 * Palliative Sedation for Brain Tumor Patients at the End of Life
, Neuro-Oncology 16(Suppl 2): ii 1-ii 112 (2014)

P18.08 * a Multicentric, Observational, non Interventional Study of Efficacy and Safety of Lacosamide for the Treatment of Epileptic Seizures in Patients with Brain Tumors
, Neuro-Oncology 16(Suppl 2): ii 112 (2014)

P18.09 * Stress induced Immune Dysfunction in Neuro-Oncology Caregivers
, Neuro-Oncology 16(Suppl 2): ii 112 (2014)

P18.10 * Assessment of Clinical Signs and Symptoms as Well as Treatment in the End of Life of Glioblastoma Patients
, Neuro-Oncology 16(Suppl 2): ii 112 (2014)

O6.04 * Granulocytic Myeloid-Derived cells Obtained from Blood Mainly Suppress T-Cell Proliferation in Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 13 (2014)

O6.05 * Erbb2/Her2-Specific Natural Killer cells for Adoptive Immunotherapy of Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 13 (2014)

O6.06 * Peripheral T cell Responses in Glioblastoma Patients Are Associated with an Improved Survival
, Neuro-Oncology 16(Suppl 2): ii 13 (2014)

O6.08 * Combined Analysis of Tert, Egfr and Idh Status Define Distinct Prognostic Classes of Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 14 (2014)

O1.05 * Axitinib, a Selective Vegfr-1,-2,-3 Tyrosine Kinase Inhibitor, Inhibits Tumor Growth and Increases Infiltration of Immune cells in an Intracranial Melanoma Mouse Model
, Neuro-Oncology 16(Suppl 2): ii 2 (2014)

O6.09 * Prostaglandin e Receptor-4 Activation Regulates Tryptophan Metabolism in Human Malignant Gliomas
, Neuro-Oncology 16(Suppl 2): ii 14 (2014)

O6.10 * Glioma cell Vegfr-2 Expression Impairs Chemotherapeutic and Antiangiogenic Treatments in Pten-Deficient Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 14 (2014)

O7.01 * Response Assessment in Neuro-Oncology (Rano) Criteria for Brain Metastases
, Neuro-Oncology 16(Suppl 2): ii 15 (2014)

O7.02 * Radiosurgery and Brain Metastases: Adequate Sequence of Brain Mri can Significantly Change the Intracranial Disease Staging
, Neuro-Oncology 16(Suppl 2): ii 15 (2014)

O7.03 * Idh-1 Mutated Glioblastomas Have a less Invasive Phenotype than Idh-1 Wild type Glioblastomas: A Diffusion Tensor Imaging Study
, Neuro-Oncology 16(Suppl 2): ii 15 (2014)

O7.04 * Dce-Mri Discriminates between Responder and Non-Responder in Recurrent High-Grade Glioma Patients Undergoing Anti-Angiogenic Treatment
, Neuro-Oncology 16(Suppl 2): ii 15-ii 16 (2014)

O7.05 * Differentiation Of Local Recurrent Brain Metastasis From Radiation-Induced Changes Using O-(2-[18F]Fluoroethyl)-L-Tyrosine Pet
, Neuro-Oncology 16(Suppl 2): ii 16 (2014)

O7.06 * Magnetic Nanoparticles Conjugated to a Recombinant Heat Shock Protein Hsp70 for Targeting Experimental Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 16 (2014)

O7.07 * Pet Imaging of Brain Gliomas with C-11 Acetate: Comparison with F-18 Fdg Pet
, Neuro-Oncology 16(Suppl 2): ii 16 (2014)

O7.08 * One-Stop Shopping In Brain Tumor Imaging: Initial Experience With Pet/Mr For Simultaneous Evaluation Of Tumor Metabolism, Structure And Blood Volume Using [18F]-Fluor-Ethyl-Thyrosine Pet And Dsc-Mri
, Neuro-Oncology 16(Suppl 2): ii 16-ii 17 (2014)

O1.06 * Novel Markers of Meningioma Aggressiveness - a Study of Meningioma versus Peritumoral Nervous Tissue
, Neuro-Oncology 16(Suppl 2): ii 2 (2014)

O7.09 * [68Ga]-Dotatate-Pet Imaging Predicts Somatostatin Receptor Ii Expression In Meningiomas
, Neuro-Oncology 16(Suppl 2): ii 17 (2014)

O7.10 * Correlation of Pre-Operative Language Fmri with Intra-Operative Direct Cortical Stimulation Findings in Glioma Surgery Identifies Potential False Positive Fmri Activations with Conventional Analysis
, Neuro-Oncology 16(Suppl 2): ii 17 (2014)

O8.01 * Pre-Operative Chemotherapy as a New Strategy in Treating low Grade Gliomas in Eloquent Areas
, Neuro-Oncology 16(Suppl 2): ii 17-ii 18 (2014)

O8.02 * Monitoring Of Treatment Response In Idh-Mutant Gliomas With In-Vivo 3D Magnetic Resonance Spectroscopy
, Neuro-Oncology 16(Suppl 2): ii 18 (2014)

O8.03 * low Grade Diffuse Astrocytoma - Prognostic Factors to Anaplastic Transformation
, Neuro-Oncology 16(Suppl 2): ii 18 (2014)

O8.04 * Temozolomide After Radiotherapy In Recurrent "Low-Grade" Diffuse Brainstem Glioma In Adults
, Neuro-Oncology 16(Suppl 2): ii 18 (2014)

O8.05 * Structural Characterization of low Grade Gliomas by Integration of Mr, Ultrasound and Pet Imaging
, Neuro-Oncology 16(Suppl 2): ii 18-ii 19 (2014)

O8.06 * Atrx and Tert Expression in Relapsing low Grade Glioma
, Neuro-Oncology 16(Suppl 2): ii 19 (2014)

O8.08 * Cic Mutation Is A Poor Prognosis Factor In 1P19Q Codeleted Gliomas, Associated To An Up-Regulation Of Proliferation Pathways
, Neuro-Oncology 16(Suppl 2): ii 19 (2014)

O1.07 * Intracranial Hemangiopericytomas Lack Typical Cytogenetic and Epigenetic Features of Meningiomas: A Comprehensive Molecular Genetic Study
, Neuro-Oncology 16(Suppl 2): ii 2-ii 3 (2014)

O8.09 * the Leeds low Grade Glioma Service 2010-13
, Neuro-Oncology 16(Suppl 2): ii 19-ii 20 (2014)

O8.10 * a Model for Research Initiatives for Rare Cancers: The Collaborative Ependymoma Research Network (Cern)
, Neuro-Oncology 16(Suppl 2): ii 20 (2014)

O9.01 * the Role of Gender in Cns Tumour Incidence and Survival
, Neuro-Oncology 16(Suppl 2): ii 20 (2014)

O9.02 * Needs of Informal Caregivers of Primary Malignant Brain Tumor Patients in the United States and the Netherlands: An International Comparison
, Neuro-Oncology 16(Suppl 2): ii 20 (2014)

O9.04 * high Grade Gliomas and Caregivers' Psychological Burden
, Neuro-Oncology 16(Suppl 2): ii 21 (2014)

O9.05 * Cognitive Functioning, Health-Related Quality of Life and Survival after Stereotactic Radiotherapy in Patients with Brain Metastases
, Neuro-Oncology 16(Suppl 2): ii 21 (2014)

O9.06 * Prognostic Relevance and Oncogenic Correlates of Epilepsy in Glioblastoma Patients
, Neuro-Oncology 16(Suppl 2): ii 21 (2014)

O9.07 * Cognitive Improvement after Meningioma Surgery
, Neuro-Oncology 16(Suppl 2): ii 21-ii 22 (2014)

O9.08 * End of Life Care in High-Grade Glioma Patients in three European Countries: A Comparative Study
, Neuro-Oncology 16(Suppl 2): ii 22 (2014)

O2.01 * Radiation Therapy Dose Painting Utilizing Fet and Fdg Pet in the Management of high Grade Glioma
, Neuro-Oncology 16(Suppl 2): ii 3 (2014)

O9.09 * Efficacy and Tolerability of Lacosamide in Patients with Glioma: A Prospective Study
, Neuro-Oncology 16(Suppl 2): ii 22 (2014)

O9.10 * Anti-Epileptic Treatment in Glioma, a Norwegian Population-Based Study
, Neuro-Oncology 16(Suppl 2): ii 22-ii 23 (2014)

O10.01 * Prognostic and Predictive Biomarker-Based Subgroups in the Noa-04 Trial
, Neuro-Oncology 16(Suppl 2): ii 23 (2014)

O10.02 * Mitotic Index, Microvascular Proliferation And Necrosis Define Three Groups Of 1P/19Q Co-Deleted Anaplastic Oligodendrogliomas Associated With Different Genomic Alterations
, Neuro-Oncology 16(Suppl 2): ii 23 (2014)

O10.03 * Physiological and Biological Responses of Human Glioblastomas to Bevacizumab Treatment Assessed by Metabolomic Flux Analysis
, Neuro-Oncology 16(Suppl 2): ii 23 (2014)

O10.04 * the Randomized, Multicenter Glarius Trial Investigating Bevacizumab/Irinotecan Vs Standard Temozolomide in Newly Diagnosed, Mgmt-Non-Methylated Glioblastoma Patients: Final Survival Results and Quality of Life
, Neuro-Oncology 16(Suppl 2): ii 23-ii 24 (2014)

O10.05 * Final Analysis of the Belob Trial (A Randomized Phase Ii Study on Bevacizumab versus Bevacizumab plus Lomustine versus Lomustine Single Agent in Recurrent Glioblastoma) and First Radiology Review Results
, Neuro-Oncology 16(Suppl 2): ii 24 (2014)

O10.06 * a Phase Ii Study of Aino (Italian Association of Neuro-Oncology) on Bevacizumab and Fotemustine for Recurrent Glioblastoma: Outcome, Patterns of Relapse and Salvage Treatments
, Neuro-Oncology 16(Suppl 2): ii 24 (2014)

O10.07 * Randomized Phase Ii Study of Axitinib Vs. Standard of Care in Patients with Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 24-ii 25 (2014)

O10.08 * high G-Protein-Coupled Receptors 65 (Gpr65) Expression Predicts a Poorer Surgical Outcome of Glioblastoma Patients
, Neuro-Oncology 16(Suppl 2): ii 25 (2014)

O2.02 * Role of an Integrated Imaging for Target Volume Definition and Radiotherapy Planning in Patients with Diagnosed high Grade Glioma
, Neuro-Oncology 16(Suppl 2): ii 3 (2014)

O10.09 * Reduction in Neutrophil-Lymphocyte Ratio during Initial Concurrent Chemoradiotherapy is Prognostic for Survival of Glioblastoma Patients
, Neuro-Oncology 16(Suppl 2): ii 25 (2014)

O10.10 * Results of Nimotuzumab and Vinorelbine, Radiation and Re-Irradiation for Diffuse Pontine Glioma in Childhood
, Neuro-Oncology 16(Suppl 2): ii 25 (2014)

S1.02 * Sublethal Irradiation Enhances Invasiveness of Malignant Glioma Cells; Implications for Radiotherapy of Human Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 25-ii 26 (2014)

S1.03 * Glioblastoma Subtypes Defined by Quantitative Imaging Map to different Canonical Signaling Pathways
, Neuro-Oncology 16(Suppl 2): ii 26 (2014)

P01.01 * Expression of Fibroblast Activation Protein Alpha in Human High-Grade Gliomas
, Neuro-Oncology 16(Suppl 2): ii 26 (2014)

P01.02 * Fibroblast Growth Factor 4 Contributes to 3-Dimensional Growth of Human Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 26-ii 27 (2014)

P01.03 * Functional Characterisation Of The Isocitrate Dehydrogenase 1 (Idh 1) R132H Mutation In Gliomas
, Neuro-Oncology 16(Suppl 2): ii 27 (2014)

P01.04 * Therapeutic Potential of Targeting Hox Protein Function in Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 27 (2014)

P01.05 * Zbtb18 Methylation Promotes Mesenchymal Transformation in Glioblastoma
, Neuro-Oncology 16(Suppl 2): ii 27 (2014)

P01.06 * Hif-1 and Hif-2 as Posible New Targets in the Treatment of von Hippel-Lindau Disease Hemangioblastomas
, Neuro-Oncology 16(Suppl 2): ii 27-ii 28 (2014)

The P53 Pathway and Ancestral Progenitors Are Associated with Tumor Recurrence in Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 3 (2014)

Integrative Genomic Characterization of Lower Grade Gliomas
, Neuro-Oncology 16(Suppl 3): iii 3 (2014)

Modelling high Myc Medulloblastoma and other Brain Tumors using Human Neural Stem cells
, Neuro-Oncology 16(Suppl 3): iii 4 (2014)

Prognostic and Predictive Biomarker-Based Subgroups in the Noa-04 Trial
, Neuro-Oncology 16(Suppl 3): iii 4 (2014)

Mif-Cd74 Guided Therapeutic Strategy for the Upfront Treatment of Gbm Patients with an Unmethylated Mgmt Promoter
, Neuro-Oncology 16(Suppl 3): iii 4-iii 5 (2014)

Sox2 Identifies the Treatment-Refractory Stem cell Population in Group 2 Medulloblastoma
, Neuro-Oncology 16(Suppl 3): iii 5 (2014)

Molecular-Based Grading in Idh-Mutant Lower Grade Gliomas
, Neuro-Oncology 16(Suppl 3): iii 5 (2014)

Tert Promoter Mutations Occur Frequently in Gliomas and a Subset of Tumors Derived from cells with low Rates of Self-Renewal
, Neuro-Oncology 16(Suppl 3): iii 5-iii 6 (2014)

"Go Or Grow" - Links Between Cellular Function, Glucose Metabolism And Glioma Microenvironment
, Neuro-Oncology 16(Suppl 3): iii 6 (2014)

Genetic Changes in Radiation-Associated Meningioma
, Neuro-Oncology 16(Suppl 3): iii 1 (2014)

Distinct Copy Number Alterations and Incidence of Chromothripsis Associated with Grade and Prognosis in Idh Mutant and Wild-Type Gliomas
, Neuro-Oncology 16(Suppl 3): iii 6 (2014)

Mutant Idh1 Suppresses Apoptosis Regulator Par-4 in Gliomas
, Neuro-Oncology 16(Suppl 3): iii 6 (2014)

Cdkn2A Loss Is Associated With Shortened Survival In Infiltrating Astrocytomas But Not Oligodendrogliomas Or Mixed Oligoastrocytomas
, Neuro-Oncology 16(Suppl 3): iii 1-iii 22 (2014)

Complex Evolutionary Dynamics Generates Genetic Diversity and Intra-Tumor Heterogeneity in Individual Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 7 (2014)

Detection of Circulating Tumor DNA in Early and Late Stage Human Malignancies
, Neuro-Oncology 16(Suppl 3): iii 7 (2014)

Novel Approach to Model Brain Tumours by Inducing Locally Restricted and Stem cell Selective Gene Targeting
, Neuro-Oncology 16(Suppl 3): iii 7 (2014)

Genetic and Epigenetic Deregulation Are Associated with the Aberrant Expression of a Stem cell Related Hox Gene Signature in Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 8 (2014)

Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations
, Neuro-Oncology 16(Suppl 3): iii 8 (2014)

The Treatment-Resistant Mesenchymal Signature in Glioblastoma Derives from Tumor cells Independent of Stroma
, Neuro-Oncology 16(Suppl 3): iii 8 (2014)

Identification of Patients with Recurrent Gbm that Benefit from Bevacizumab
, Neuro-Oncology 16(Suppl 3): iii 8-iii 9 (2014)

Mutation-Based Molecular Glioma Classification: Prevalence and Association with Germline Risk Snps
, Neuro-Oncology 16(Suppl 3): iii 1 (2014)

Astrocytic Tumors With Gain On 7Q And Those With Gain Of Whole Chromosome 7 Belong To Distinct Subgroups Characterized By Various Genetic Factors Including Idh1 And Tp53
, Neuro-Oncology 16(Suppl 3): iii 9 (2014)

Interplay of Lipid Droplets and Autophagy Regulates Glioblastoma Survival
, Neuro-Oncology 16(Suppl 3): iii 9 (2014)

Vasculogenesis in von Hippel-Lindau Disease Associated Tumors
, Neuro-Oncology 16(Suppl 3): iii 9 (2014)

Frequent H3F3A K27M Mutations In Thalamic Gliomas From Young Adult Patients
, Neuro-Oncology 16(Suppl 3): iii 9-iii 10 (2014)

Image Guided Rna-Seq Reveals Subtype-Specific Patterns at the Infiltrative Margins of Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 10 (2014)

Annexin A2 Regulates Angiogenesis and Invasion Phenotypes of Malignant Glioma
, Neuro-Oncology 16(Suppl 3): iii 10 (2014)

Intraoperative Contrast Enhanced Ultrasound in Brain Tumor Surgery
, Neuro-Oncology 16(Suppl 3): iii 10 (2014)

Novel Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy
, Neuro-Oncology 16(Suppl 3): iii 10-iii 11 (2014)

Information-Guided Surgery using Intraoperative Mri and Functional Mapping for Gliomas
, Neuro-Oncology 16(Suppl 3): iii 11 (2014)

In Situ Metabolic Profiling Sheds Light on Oxidative Stress Pathways in Idh1 Mutant Oligodendroglioma
, Neuro-Oncology 16(Suppl 3): iii 11 (2014)

Telomere Length Variants Are Associated with High-Grade Glioma Risk: Identification of a Novel Glioma Risk Locus by Genome-Wide Association Study
, Neuro-Oncology 16(Suppl 3): iii 2 (2014)

Immune Checkpoint Blockade for Glioblastoma: Preclinical Activity of Single Agent and Combinatorial Therapy
, Neuro-Oncology 16(Suppl 3): iii 11-iii 12 (2014)

Metabolic Imaging Biomarkers for Mutant Idh1 Gliomas
, Neuro-Oncology 16(Suppl 3): iii 12 (2014)

Increased Perfusion Due to Vascular Normalization Improves Oxygenation and Survival in Glioblastoma Patients Treated with Cediranib with or without Chemoradiation
, Neuro-Oncology 16(Suppl 3): iii 12 (2014)

Imaging Biomarkers of Malignant Progression of Diffuse Low-Grade Gloma (Lgg)
, Neuro-Oncology 16(Suppl 3): iii 1-iii 22 (2014)

Ex Vivo Metabolic Signatures of Gliomas Based upon Tumor Grade, Imaging Characteristics and Treatment History
, Neuro-Oncology 16(Suppl 3): iii 12-iii 13 (2014)

Prognostic Value Of O-(2-[18F]Fluorethyl)-L-Tyrosine Positron Emission Tomography (18Fet-Pet) Within The Clinical Course In Newly Diagnosed Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 13 (2014)

A Phase I Study of Convection-Enhanced Delivery of Liposomal-Irinotecan using Real-Time Imaging with Gadolinium in Patients with Recurrent high Grade Glioma
, Neuro-Oncology 16(Suppl 3): iii 13 (2014)

Preoperative Dynamic Contrast-Enhanced Mri Correlates with Molecular Markers of Hypoxia and Vascularity in Specific Areas of Intratumoral Microenvironment and is Predictive of Patient Outcome
, Neuro-Oncology 16(Suppl 3): iii 13 (2014)

Real-Time Atlas-Based Stereotactic Neuronavigation
, Neuro-Oncology 16(Suppl 3): iii 14 (2014)

Brain Tumor Surgery Navigation System Based on Updating Preoperative Images using Positional Information of Surgical Tools
, Neuro-Oncology 16(Suppl 3): iii 14 (2014)

Tree Derived Survival Risk Groups in Differentiating Risk for Glioma Patients
, Neuro-Oncology 16(Suppl 3): iii 2 (2014)

Glioblastoma Stem Cell-Derived Pericytes and Tumor Angiogenesis
, Neuro-Oncology 16(Suppl 3): iii 14 (2014)

Single cell Derived Clonal Analysis of Human Glioblastoma Links Functional and Genomic Heterogeneity
, Neuro-Oncology 16(Suppl 3): iii 14 (2014)

Mutant Egfr Suppression of Microrna-9 Induces Foxp1 to Enhance Glioblastoma Tumorigenicity
, Neuro-Oncology 16(Suppl 3): iii 14-iii 15 (2014)

Presence of a Distinctive Myeloid Population is Associated with the Invasive Tumor Phenotype Observed after Anti-Angiogenesis Therapies
, Neuro-Oncology 16(Suppl 3): iii 15 (2014)

Epigenetic Regulation of Gbm cell Stemness and Tumor Propagating Capacity by Oct4 and Sox2
, Neuro-Oncology 16(Suppl 3): iii 15 (2014)

Moving beyond Vegf: Inhibing Glioma Angiogenesis by Targeting the Tie2/Angiopoietin Signaling Pathway
, Neuro-Oncology 16(Suppl 3): iii 15 (2014)

Target Identification in Glioma Initiating cells
, Neuro-Oncology 16(Suppl 3): iii 15-iii 16 (2014)

Epigenome Alterations Define Lethal Cimp Positive Ependymomas of Infancy
, Neuro-Oncology 16(Suppl 3): iii 16 (2014)

Understanding and Tackling the Tumor-Immune cell Dialogue during Progression and Therapeutic Resistance
, Neuro-Oncology 16(Suppl 3): iii 16 (2014)

Egfr Phosphorylation of Dcbld2 Recruits Traf6 and Stimulates Akt-Promoted Tumorigenesis
, Neuro-Oncology 16(Suppl 3): iii 16-iii 17 (2014)

Development of Novel small Molecules that Target Glioblastoma Stem cells
, Neuro-Oncology 16(Suppl 3): iii 17 (2014)

Integration of Cancer Stem cell Maintenance and Lipid Metabolism by Scavenger Receptors
, Neuro-Oncology 16(Suppl 3): iii 17 (2014)

Distinct and Separable Roles for Histone Methyltransferase Ezh2 in Neurogenic Astrocytes
, Neuro-Oncology 16(Suppl 3): iii 17 (2014)

A Novel Polycomb Feed Forward Loop in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 3): iii 17 (2014)

Extracellular Regulators of Glioblastoma Signaling
, Neuro-Oncology 16(Suppl 3): iii 18 (2014)

Molecular Motors as Novel Targets to Block Glioma Dispersion and Proliferation
, Neuro-Oncology 16(Suppl 3): iii 18 (2014)

Cell Intrinsic Sexual Dimorphism in the Rb and P21 Pathways Underlies Male Predominance in Gbm
, Neuro-Oncology 16(Suppl 3): iii 18-iii 19 (2014)

Integrated Analysis Identifies different Metabolic Signatures within Both Tumor-Initiating cells and Stem cells in a Murine Glioblastoma Model
, Neuro-Oncology 16(Suppl 3): iii 19 (2014)

Single Nucleotide Polymorphisms (Snps) Associated with Glioma Survival
, Neuro-Oncology 16(Suppl 3): iii 2 (2014)

A Novel P53 Bystander effect Induces Glioblastoma cell Death through a Glycosylation-Dependent Mechanism
, Neuro-Oncology 16(Suppl 3): iii 19 (2014)

Aberrant Splicing of a Brain-Enriched Alternative Exon Eliminates Tumor Suppressor Function and Promotes Oncogene Function during Brain Tumorigenesis
, Neuro-Oncology 16(Suppl 3): iii 19-iii 20 (2014)

Combined Drug Screening and Phosphoproteomics Identifies Candidate Brain Tumor Therapeutics and Novel Targets in Primary Human Brain Tumor-Initiating cells
, Neuro-Oncology 16(Suppl 3): iii 20 (2014)

The Warburg effect and beyond
, Neuro-Oncology 16(Suppl 3): iii 20 (2014)

Hur Dependent Regulation of Centrosomes
, Neuro-Oncology 16(Suppl 3): iii 20 (2014)

Epigenetically Disturbed Neural Stem/Progenitor cells in the Pre-Neoplastic Stage of Pdgf-Induced Mouse Glioma
, Neuro-Oncology 16(Suppl 3): iii 20-iii 21 (2014)

Stem- and Progenitor-Like cell Contribution to Malignant Astrocytoma Heterogeneity
, Neuro-Oncology 16(Suppl 3): iii 21 (2014)

Procoagulant Tissue Factor Expression is linked to Distinct Subtypes in Glioblastoma and Plays a Role in Tumor Dormancy
, Neuro-Oncology 16(Suppl 3): iii 1-iii 22 (2014)

Mechanisms of Adaptive Radioprotection in Glioma Stem cells
, Neuro-Oncology 16(Suppl 3): iii 21 (2014)

Inhibiting Invasion and Stemness in Glioblastoma by Thymosin Beta 4 Gene Silencing: A Potential Therapeutic Target?
, Neuro-Oncology 16(Suppl 3): iii 21-iii 22 (2014)

Initial Symptoms of Pineal Region Tumors - Comparison to Historical Control of Pre-Ct Era -
, Neuro-Oncology 16(Suppl 3): iii 3 (2014)

Function of Ecotropic Viral Integration Site 1 (Evi1) Gene in Mouse Neural Precursor cells and Human Glioma Initiating cells
, Neuro-Oncology 16(Suppl 3): iii 22 (2014)

Phase I Individual Dose Titration Trial of the Human Corticotropin-Releasing Factor (Hcrf), Corticorelin Acetate Injection (Xerecept) in Pediatric Patients with Peritumoral Edema of the Brain
, Neuro-Oncology 16(Suppl 3): iii 23 (2014)

Transcriptional Regulation of Oligodendroglial cell Fate by Dlx Homeobox Genes: Potential Relevance to Histone H3.3 Mutations in Pediatric high Grade Glioma
, Neuro-Oncology 16(Suppl 3): iii 25 (2014)

Pid1 is a Novel Sensitizer of Brain Tumor cells to Chemotherapy
, Neuro-Oncology 16(Suppl 3): iii 26 (2014)

Preliminary Results Of A Prospective Feasibility Pilot Study Of "Gempox" (Gemcitabine, Oxaliplatin, And Paclitaxel) In Pediatric And Adult Patients With Refractory Or Recurrent Central Nervous System (Cns) Germ Cell Tumors (Gct): The International Cns Gct Consortium Trial, Cns Gct-4
, Neuro-Oncology 16(Suppl 3): iii 26 (2014)

Biologically-Based Therapeutics for the Treatment of Diffuse Intrinsic Pontine Gliomas
, Neuro-Oncology 16(Suppl 3): iii 26 (2014)

Detailed Molecular Characterisation of Diffuse Intrinsic Pontine Gliomas Identifies three Molecular Subgroups and a Novel Cancer Driver, Acvr1
, Neuro-Oncology 16(Suppl 3): iii 26-iii 27 (2014)

Final Results of a Prospective Multi-Institutional Phase Ii Study of Everolimus (Rad001), an Mtor Inhibitor, in Pediatric Patients with Recurrent or Progressive Low-Grade Glioma. A Poetic Consortium Trial
, Neuro-Oncology 16(Suppl 3): iii 27 (2014)

Potency of Secreting Hcg- in Germinomas. Clinical and Biological Analysis
, Neuro-Oncology 16(Suppl 3): iii 27 (2014)

Prognostic Marker Analysis in Pediatric Posterior Fossa Ependymomas
, Neuro-Oncology 16(Suppl 3): iii 27 (2014)

Targeting Resistance Pathways in Braf-Mutant Pediatric Gliomas
, Neuro-Oncology 16(Suppl 3): iii 27-iii 28 (2014)

Intracranial Germ cell Tumors with Mtor Mutation Are Common in Basal Ganglia
, Neuro-Oncology 16(Suppl 3): iii 28 (2014)

Whole Exome Sequencing Identified That The Mapk And Pi3K Pathways Are The Main Targets For Mutations In Intracranial Germ Cell Tumors
, Neuro-Oncology 16(Suppl 3): iii 23 (2014)

Metastasis and Tumor Recurrence from Rare Sox9-Positive cells in Mycn-Driven Medulloblastoma
, Neuro-Oncology 16(Suppl 3): iii 28 (2014)

Long-Term Outcome of Centrally Located Low-Grade Glioma in Children
, Neuro-Oncology 16(Suppl 3): iii 28 (2014)

High-Throughput Drug Screening Identifies Hdac Inhibitors as Candidate Therapeutics for Myc-Driven Medulloblastoma
, Neuro-Oncology 16(Suppl 3): iii 29 (2014)

C19Mc Oncomirs Converge On Multiple Cell Cycle Regulators To Modulate Neural Differentiation And The Tumor Epigenome
, Neuro-Oncology 16(Suppl 3): iii 29 (2014)

Highly Selective Intra-Arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (Dipg)
, Neuro-Oncology 16(Suppl 3): iii 29 (2014)

Kiaa1549:Braf Fusion Gene In Pediatric Brain Tumors Of Different Histogenesis
, Neuro-Oncology 16(Suppl 3): iii 29 (2014)

Histopathologic Evaluation Of H3K27Me3 Is A Prognostic Biomarker For Pediatric Glioblastomas
, Neuro-Oncology 16(Suppl 3): iii 29-iii 30 (2014)

Convection-Enhanced Delivery of Nimustine Hydrochloride for Brainstem Malignant Glioma: Current Study and Development of New Device
, Neuro-Oncology 16(Suppl 3): iii 30 (2014)

Quality of Life of Extremely Long-Time Survivors with Germinoma Mainly Treated with Radiotherapy
, Neuro-Oncology 16(Suppl 3): iii 30 (2014)

Thor Methylation Provides Insight into the Telomere Maintenance Landscape of Malignant Gliomas
, Neuro-Oncology 16(Suppl 3): iii 30 (2014)

Molecular (Re-)Classification Of Cns-Primitive Neuroectodermal Tumors
, Neuro-Oncology 16(Suppl 3): iii 23 (2014)

Histone Deacetylase Inhibitor Pci-24781 Shows Antiproliferative effects against Pediatric Glioblastoma cells
, Neuro-Oncology 16(Suppl 3): iii 30-iii 31 (2014)

Mtor Kinase Inhibitors and Apoptosis in Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 31 (2014)

Optimization of Demethylating Therapy for Idh1 Mutant Gliomas
, Neuro-Oncology 16(Suppl 3): iii 31 (2014)

Identifying Drug Compounds Targeting Tumor Metabolism in Glioblastomas
, Neuro-Oncology 16(Suppl 3): iii 31 (2014)

A C-Met-ss1 Integrin Complex Drives Invasive Resistance To Anti-Angiogenic Therapy
, Neuro-Oncology 16(Suppl 3): iii 31-iii 32 (2014)

Mapping The Glioblastoma Metabolome After Bevacizumab Therapy By 13C6-Glucose Metabolomic Flux Analysis
, Neuro-Oncology 16(Suppl 3): iii 32 (2014)

High-Throughput Screening of Glioma Stem cell Lines for Drug Structure- and Genotype-Correlated Sensitivity to a Panel of Tyrosine Kinase Inhibitors
, Neuro-Oncology 16(Suppl 3): iii 32 (2014)

High Interstitial Fluid Pressure Regulates Tumor Growth and Drug Uptake in Human Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 32 (2014)

Mutant Idh1-Driven Cellular Transformation Increases Rad51-Mediated Homologous Recombination and Temozolomide (Tmz) Resistance
, Neuro-Oncology 16(Suppl 3): iii 33 (2014)

An All Human 3D In Vitro Model Of The Blood Brain Barrier In Nanoparticle Delivery And Cancer Metastasis Studies
, Neuro-Oncology 16(Suppl 3): iii 33 (2014)

Structural Variants Shuffle Chromatin to Activate Gfi1 Family Oncogenes in Medulloblastoma
, Neuro-Oncology 16(Suppl 3): iii 24 (2014)

Influence Of Drug Delivery On Therapeutic Benefit In Gbm-Cdk4 And Mdm2 Inhibitor Comparison In Flank Versus Orthotopic Models And Comparison Of Brain Penetrant Versus Impenetrant Pi3K/Mtor Inhibitors
, Neuro-Oncology 16(Suppl 3): iii 33 (2014)

Rb1 Suppression is Responsible for Acquired Cdk4/6 Inhibitor Resistance in Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 33-iii 34 (2014)

Ephrina2 Receptor in Human Glioblastoma Cancer Stem cells and Identification of New, Putative Therapeutic Targets
, Neuro-Oncology 16(Suppl 3): iii 34 (2014)

Transcriptional Profiling of Gbm Invasive Genes Identifies Effective Inhibitors of the Lim Kinase-Cofilin Pathway
, Neuro-Oncology 16(Suppl 3): iii 34 (2014)

Identification and Preliminary Treatment Data of Xenografts Representing Tcga-Defined Subtypes
, Neuro-Oncology 16(Suppl 3): iii 35 (2014)

Brain Tumour Initiating cells and Targeting Stat3 Oncogenic Signalling in Gbm
, Neuro-Oncology 16(Suppl 3): iii 35 (2014)

Foretinib is Effective Therapy for Metastatic Sonic Hedgehog Medulloblastoma
, Neuro-Oncology 16(Suppl 3): iii 35 (2014)

Neo212: A Novel Temozolomide-Perillyl Alcohol Conjugate Exhibits Superior Activity against Temozolomide Resistant Gliomas and Intracranial Triple Negative Breast Cancer Metastasis
, Neuro-Oncology 16(Suppl 3): iii 35-iii 36 (2014)

Direct cell Contact between Brain Endothelial cells and Glioma Stem cells Promotes Endothelial cell Migration
, Neuro-Oncology 16(Suppl 3): iii 36 (2014)

Assessing the Utility of Clinical Tumor Sequencing in the Pediatric Neuro-Oncology Clinic
, Neuro-Oncology 16(Suppl 3): iii 24 (2014)

Effects of Simulated Microgravity on Proliferation and Chemosensitivity in Malignant Glioma cells
, Neuro-Oncology 16(Suppl 3): iii 36 (2014)

Mre11-Rad50-Nbs1 Complex Inhibitor Mirin Enhances Radiosensitivity in Human Glioblastoma cells
, Neuro-Oncology 16(Suppl 3): iii 36 (2014)

Glioma Specific Peptides: A Platform for Molecular Imaging and Therapeutic Targeting
, Neuro-Oncology 16(Suppl 3): iii 37 (2014)

Different Mechanisms of Tumor Growth Inhibition by Blockade of Igf-Ir in U87-Induced and Stem-Like Cell-Induced Glioblastomas
, Neuro-Oncology 16(Suppl 3): iii 37 (2014)

Trail Potentiates Panobinostat Cytotoxicity in Glioblastoma Multiforme (Gbm) in Vitro
, Neuro-Oncology 16(Suppl 3): iii 37 (2014)

Micro RNA Based Strategy for Enhancing the effect of Oncolytic Hsv-1 Virus Therapy
, Neuro-Oncology 16(Suppl 3): iii 37 (2014)

Deciphering Intrinsic And Adaptive Resistance To Pi3K Pathway Inhibitors In Glioma
, Neuro-Oncology 16(Suppl 3): iii 37-iii 38 (2014)

Patient-Derived Xenografts Mirror the Proteomic Profile of Human Glioblastoma: Implications for Personalized Drug Development
, Neuro-Oncology 16(Suppl 3): iii 38 (2014)

Cabozantinib is Effective in a Subset of Xenograft Gbm Tumors and Affects Multiple Signaling Pathways
, Neuro-Oncology 16(Suppl 3): iii 38 (2014)

Yap is a Critical and Novel Regulator of Migration and Invasion and Predicts Poor Outcome in Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 38-iii 39 (2014)

Informing Treatment Decisions in Relapsed Pediatric Malignancies using Next-Generation Diagnostics
, Neuro-Oncology 16(Suppl 3): iii 24 (2014)

First-In-Human Phase I Clinical Trial of Oncolytic Delta-24-Rgd (Dnx-2401) with Biological Endpoints: Implications for Viro- Immunotherapy
, Neuro-Oncology 16(Suppl 3): iii 39 (2014)

The Impact of Oxygen Tension on Cd8+ T cell Function and Interaction with Glioma cells
, Neuro-Oncology 16(Suppl 3): iii 40 (2014)

Idh1 Mutations as a Immunotherapeutic Target for Brain Tumors
, Neuro-Oncology 16(Suppl 3): iii 40 (2014)

Functional Presence of M2 Macrophage Markers in Gbm Tumor cells
, Neuro-Oncology 16(Suppl 3): iii 40-iii 41 (2014)

New Glioma-Associated Auto-Antibodies
, Neuro-Oncology 16(Suppl 3): iii 41 (2014)

Gliomas Promote Induction of B7-H1/Pd-L1 Expression on Monocytes: Clinical Evidence of an Immunosuppressive Mechanism that can be Targeted with Antibody Blockade
, Neuro-Oncology 16(Suppl 3): iii 41 (2014)

Oncolytic Poliovirus Immunotherapy of Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 41 (2014)

Prognostic Significance of Clinical, Histopathological, and Molecular Characteristics of Medulloblastomas in the Prospective Hit2000 Multicenter Clinical Trial Cohort
, Neuro-Oncology 16(Suppl 3): iii 24-iii 25 (2014)

Abcg2 and Mdr Promote Brainstem Gliomagenesis and limit the Efficacy of Dasatinib in a Diffuse Intrinsic Pontine Glioma (Dipg) Mouse Model
, Neuro-Oncology 16(Suppl 3): iii 25 (2014)

Epigenetic Targeting of Hedgehog Pathway Transcriptional Output
, Neuro-Oncology 16(Suppl 3): iii 25 (2014)

Spontaneous Immune Responses in Gbm Patients after Complete Tumor Resection Are Associated with an Improved Survival
, Neuro-Oncology 16(Suppl 3): iii 42 (2014)

The Role of Myeloid Derived Suppressor cells (Mdscs) in Tumor-Induced Immunosuppression in Human and Murine Gliomas
, Neuro-Oncology 16(Suppl 3): iii 44 (2014)

Beneficial Outcomes after Pcv plus Rt in Oligodendroglial Tumors Are Associated with Detection or Risk of an Idh Mutation
, Neuro-Oncology 16(Suppl 3): iii 44-iii 45 (2014)

Tert Promoter Mutations Contribute to Prognostic Subgroups of Lower Grade Astrocytomas
, Neuro-Oncology 16(Suppl 3): iii 45 (2014)

Pre-Operative Chemotherapy as a New Strategy of Treatment for low Grade Gliomas in Eloquent Areas
, Neuro-Oncology 16(Suppl 3): iii 45 (2014)

Elucidating the Oncogenic Role of Atrx Deficiency in Glioma
, Neuro-Oncology 16(Suppl 3): iii 45 (2014)

Evolution of the Glioblastoma Genome in Response to Treatments
, Neuro-Oncology 16(Suppl 3): iii 45-iii 46 (2014)

Targeting Glioma Initiating cells in Gbm: Abtc-0904, a Randomized Phase 0/Ii Study Targeting the Sonic Hedgehog-Signaling Pathway
, Neuro-Oncology 16(Suppl 3): iii 46 (2014)

Association of Cd133 Expression and Idh Mutation with Recurrence Pattern in high Grade Gliomas
, Neuro-Oncology 16(Suppl 3): iii 46 (2014)

Molecular Genetic Determinants of Long-Term Survival with Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 46-iii 47 (2014)

Phase Ii Trial Of The Phosphatidyinositol-3 Kinase (Pi3K) Inhibitor Buparlisib (Bkm120) In Recurrent Glioblastoma Conducted By The Ivy Foundation Early Phase Clinical Trials Consortium
, Neuro-Oncology 16(Suppl 3): iii 47 (2014)

Rapid Idh1 Gene Mutation Analysis for Intraoperative Pathological Diagnosis
, Neuro-Oncology 16(Suppl 3): iii 47 (2014)

Glioma Surgery: Tailoring Intraoperative Neurophysiological Strategies to Clinical Conditions Enhances Resection, Extends Indications, and Keeps Patient Functional Integrity
, Neuro-Oncology 16(Suppl 3): iii 47 (2014)

Association of Matrix Metalloproteinase 2 (Mmp2) Baseline Plasma Level with Response and Survival and Change Overtime in Patients Treated with Bevacizumab for Recurrent high Grade Glioma
, Neuro-Oncology 16(Suppl 3): iii 48 (2014)

Everolimus (Rad001) and the Mtor Pathway in Low-Grade Gliomas
, Neuro-Oncology 16(Suppl 3): iii 48 (2014)

Proficiency Performance Benchmarks for Removal of Simulated Brain Tumors using Neurotouch
, Neuro-Oncology 16(Suppl 3): iii 48 (2014)

A 3-Dimensional Matrix Assay that may Help Predict Treatment Response to Temozolomide in Patients with Gliobastoma: Subgroup Analysis of Patients Undergoing Mgmt Testing
, Neuro-Oncology 16(Suppl 3): iii 48 (2014)

Prognostic Factors for Primary Central Nervous System Lymphomas Treated with High-Dose Methotrexate-Based Chemo-Radiotherapy
, Neuro-Oncology 16(Suppl 3): iii 49 (2014)

A "Precision Medicine" Strategy For Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 49 (2014)

Intra-Operative Mapping of Neural Networks during Awake Craniotomy for Resection of Brain Tumors: Work in Progress
, Neuro-Oncology 16(Suppl 3): iii 49 (2014)

Nk cells from Glioma-Bearing Mice Treated with Temozolomide Are Enriched for Genes Related to Multi-Drug Resistance and Chemotaxis
, Neuro-Oncology 16(Suppl 3): iii 42-iii 52 (2014)

Results of the International Interlaboratory Comparison of Mgmt Promoter Methylation Analysis Involving Twenty-Three Academic Centers in Germany, Austria and the Netherlands
, Neuro-Oncology 16(Suppl 3): iii 49-iii 50 (2014)

Brain Tumor Care Through The Patient'S Eyes -- The Value Of A Comprehensive Brain Tumor Center
, Neuro-Oncology 16(Suppl 3): iii 50 (2014)

Molecular-Guided Neoadjuvant Approach for Chemosensitive Gliomas
, Neuro-Oncology 16(Suppl 3): iii 50 (2014)

Repeated Intranasal Application of Neural Stem Cell-Mediated Enzym/Prodrug Therapy using a Novel Hsv-Thymidine Kinase Variant Improves Therapeutic Efficiency in an Intracranial Glioblastoma Model
, Neuro-Oncology 16(Suppl 3): iii 50 (2014)

Temozolomide for Recurrent Intracranial Ependymoma of the Adult: Patterns of Response, Survival and Correlations with Mgmt Promoter Methylation
, Neuro-Oncology 16(Suppl 3): iii 50-iii 51 (2014)

Clinical Trials of a Third-Generation Recombinant Oncolytic Hsv-1 in Recurrent Glioblastoma and Olfactory Neuroblastoma Patients
, Neuro-Oncology 16(Suppl 3): iii 51 (2014)

Genetic And Histological Stability Of Oligodendroglial Tumors With 1P/19Q Co-Deletion Even After Chemotherapy And Or Radiation Therapy
, Neuro-Oncology 16(Suppl 3): iii 51 (2014)

Quantification of Proneural Gene-Expression Signature of Gliomas and Glioblastoma-Derived Spheres
, Neuro-Oncology 16(Suppl 3): iii 51 (2014)

Clonal Evolution of Gliomas is Encoded in the Evolutionary Dynamics of DNA Methylation
, Neuro-Oncology 16(Suppl 3): iii 51-iii 52 (2014)

Effect of Temozomide on Human Dendritic cells
, Neuro-Oncology 16(Suppl 3): iii 42-iii 43 (2014)

Oncolytic Polio/Rhinovirus Recombinant (Pvsripo) in Recurrent Glioblastoma (Gbm): First Phase I Clinical Trial Evaluating the Intratumoral Administration
, Neuro-Oncology 16(Suppl 3): iii 43 (2014)

Next-Generation Recombinant Immunotoxins for Glioblastomas and Melanomas Treatment
, Neuro-Oncology 16(Suppl 3): iii 43 (2014)

Genome-Wide Analysis Uncovers Recurrent Alterations in Primary Central Nervous System Lymphomas (Pcnsl)
, Neuro-Oncology 16(Suppl 3): iii 43 (2014)

Loss of Sparc in P53-Null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor cell Survival
, Neuro-Oncology 16(Suppl 3): iii 44 (2014)

Erbb2/Her2-Specific Natural Killer cells for Adoptive Immunotherapy of Glioblastoma
, Neuro-Oncology 16(Suppl 3): iii 44 (2014)

At-11 * Final Results from the Randomized Phase Ii Trial Avareg (Ml25739) with Bevacizumab (Bev) or Fotemustine (Ftm) in Recurrent Gbm
, Neuro-Oncology 16(Suppl 5): v10 (2014)

At-12 * Phase 1/2 Study of Th-302, Investigational Hypoxia-Activated Prodrug, and Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v10-v11 (2014)

At-13 * R9802: Phase Iii Study of Radiation Therapy (Rt) with or without Procarbazine, Ccnu, and Vincristine (Pcv) in Low-Grade Qlioma: Results by Histologic type
, Neuro-Oncology 16(Suppl 5): v11 (2014)

At-14 * Long-Term Progression-Free Survival of Recurrent Glioblastoma Multiforme Treated with a Combination of Targeted Agents: A Case Report
, Neuro-Oncology 16(Suppl 5): v11 (2014)

At-15 * a Phase Ii Study of Antineoplastons A10 and As2-1 in Patients with Brainstem Gliomas Final Report (Protocol Bt-11)
, Neuro-Oncology 16(Suppl 5): v11 (2014)

At-16 * Phase Ii Study of Tivozanib, an Oral Vegfr Inhibitor, in Patients with Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v11 (2014)

At-17 * Re-Analysis of Pfs/Response using Original Macdonald Criteria and Response Evaluation Criteria in Solid Tumors in the Phase Iii Avaglio Study of Bevacizumab plus Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma
, Neuro-Oncology 16(Suppl 5): v12 (2014)

At-18 * Survival Analysis Of Patients With A Pfs Event Who Did Not Receive Post-Progression Therapy In Avaglio (Bevacizumab [Bev] Plus Radiotherapy [Rt] And Temozolomide [Tmz] For Newly Diagnosed Glioblastoma [Gbm])
, Neuro-Oncology 16(Suppl 5): v12 (2014)

At-19 * Single Institution Retrospective Comparison of Glioblastoma (Gbm) Patients (Pts) Initiated on Bevacizumab (Bev) before versus after Recurrence in Clinical Practice
, Neuro-Oncology 16(Suppl 5): v12 (2014)

At-02 * Intratumoral Delivery of the Retroviral Replicating Vector (Rrv) Toca 511 in Subjects with Recurrent high Grade Glioma: Interim Report of Phase 1 Study (Nct 01156584)
, Neuro-Oncology 16(Suppl 5): v8 (2014)

At-20 * Single Institution Retrospective Review of Performance Status and Corticosteroid Use in Newly Diagnosed Glioblastoma (Gbm) Patients (Pts) Treated on Bevacizumab (Bev)
, Neuro-Oncology 16(Suppl 5): v12-v13 (2014)

At-21 * Final Results of a Phase 1 Trial of an Oncolytic Polio/Rhinovirus Recombinant (Pvsripo) against Recurrent Glioblastoma (Gbm)
, Neuro-Oncology 16(Suppl 5): v13 (2014)

At-22 * Phase Ii Trial of Bevacizumab, Radiation Therapy (Rt) and Temozolomide Followed by Bevacizumab and Temozolomide with Continuation of Bevacizumab beyond Progression
, Neuro-Oncology 16(Suppl 5): v13 (2014)

At-23 * a Phase Ii Study of Lapatinib and Dose-Dense Temozolomide (Tmz) for Adults with Recurrent Ependymoma: A Cern Clinical Trial
, Neuro-Oncology 16(Suppl 5): v13 (2014)

At-24 * Phase 1/2 Trial of Bevacizumab plus Tpi 287, a Novel Brain Penetrable Anti-Microtubule Agent, for the Treatment of Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v13-v14 (2014)

At-25 * a Phase I Study of Convection-Enhanced Delivery of Liposomal-Irinotecan using Real-Time Imaging with Gadolinium in Patients with Recurrent high Grade Glioma
, Neuro-Oncology 16(Suppl 5): v14 (2014)

At-26 * Clinical Management and Outcome of Histologically Verified Adult Brainstem Gliomas in Switzerland: A Retrospective Analysis of 21 Patients
, Neuro-Oncology 16(Suppl 5): v14 (2014)

At-28 * Long-Term Survival (Over 15 Years) of Pathologically Confirmed Recurrent Glioblastoma Multiforme: A Case Report
, Neuro-Oncology 16(Suppl 5): v14-v15 (2014)

At-29 * Intravenous Administration of Toca 511 in Patients with Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v15 (2014)

At-03 * Phase I Trial of Enzastaurin (Ly 317615) in Combination with Carboplatin in Adults with Recurrent Glioma
, Neuro-Oncology 16(Suppl 5): v8 (2014)

At-30 * effects of Everolimus on Meningioma Growth in Patients with Neurofibromatosis type 2
, Neuro-Oncology 16(Suppl 5): v15 (2014)

At-31 * a Canadian Questionnaire on the Management of Adult Diffuse low Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v15 (2014)

At-33 * a Phase Ii Study of Concurrent Radiation Therapy, Temozolomide and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v15-v16 (2014)

At-34 * Construction of an Integrated Diagnostic Algorithm Consisting of Consensus Histologic and Molecular Parameters of two Eortc Trials on Anaplastic Glioma
, Neuro-Oncology 16(Suppl 5): v16 (2014)

At-35 * Intermittent High Dose (Pulsatile) Erlotinib For EgfrvIii Mutant Recurrent Malignant Gliomas: A Pilot Clinical Trial
, Neuro-Oncology 16(Suppl 5): v16 (2014)

At-36 * Panobinostat in Combination with Bevacizumab for Recurrent Glioblastoma and Anaplastic Glioma
, Neuro-Oncology 16(Suppl 5): v16 (2014)

At-37 * Phase I Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v16-v17 (2014)

At-39 * a Randomized Phase Ii Trial of Vandetanib (Zd6474) in Combination with Carboplatin versus Carboplatin Alone in Adults with Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v17 (2014)

At-40 * Prognosis Factors in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v17 (2014)

At-04 * a Randomized Phase Ii Trial of Vandetanib in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent Anaplastic Astrocytoma
, Neuro-Oncology 16(Suppl 5): v8-v9 (2014)

At-41 * Multi-Center Clinical Trial of Intravenous Administration of Bevacizumab for the Treatment of Radiation Necrosis in the Brain to Obtain Nda Application for on Label Use in Japan
, Neuro-Oncology 16(Suppl 5): v17 (2014)

At-42 * Factors Associated with Malignant Transformation of Low-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v17-v18 (2014)

At-43 * Multi-Centre, Randomized, Double-Blind Phase Ii Study Comparing Cediranib (Azd2171) plus Gefitinib (Iressa, Zd1839) with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
, Neuro-Oncology 16(Suppl 5): v18 (2014)

At-44 * Relearning Neuro-Oncology: Bayes' Theorem Provides a New World Order
, Neuro-Oncology 16(Suppl 5): v18 (2014)

At-45 * Gamma Knife Radiosurgery for Recurrent high Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v18 (2014)

At-46 * Vorinostat and Bevacizumab for Recurrent High-Grade Glioma: Interim Analysis of a Phase Ii Clinical Trial
, Neuro-Oncology 16(Suppl 5): v18 (2014)

At-47 * Phase I Trial of Intrathecal Trastuzumab in Her2 Positive Leptomeningeal Metastases
, Neuro-Oncology 16(Suppl 5): v19 (2014)

At-48 * a Phase 1 Trial of Carboxyamidotriazole Orotate (Cto) in Combination with Bevacizumab for Adult Patients with Recurrent Malignant Glioma Post-Bevacizumab Failure
, Neuro-Oncology 16(Suppl 5): v19 (2014)

At-49 * Safety Evaluation of High-Dose Bcnu-Loaded Biodegradable Implants in Chinese Patients with Recurrent Malignant Gliomas
, Neuro-Oncology 16(Suppl 5): v19 (2014)

At-50 * Ala-Based Photodynamic Therapy in Recurrent Malignant Glioma - a Pilot Study
, Neuro-Oncology 16(Suppl 5): v19 (2014)

At-05 * Phase Ii Study of Ifosfamide, Carboplatin, and Etoposide Inpatients with a First Recurrence of Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v9 (2014)

At-51 * Phase I Study of Panobinostat and Fractionated Stereotactic Re-Irradiation Therapy (Fsrt) for Recurrent high Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v19-v20 (2014)

At-52 * Prospective Early Results of low Grade Glioma Patients Treated with Proton Therapy
, Neuro-Oncology 16(Suppl 5): v20 (2014)

At-53 * Phase I/Ii Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioblastoma Multiforme (Gbm)
, Neuro-Oncology 16(Suppl 5): v20 (2014)

At-54 * Thermotherapy with Coated Iron Oxide Nanoparticles Radiotherapy versus Radiotherapy Alone in Recurrent Glioblastoma: An Open-Label Randomized Controlled Study
, Neuro-Oncology 16(Suppl 5): v20 (2014)

At-55 * Final Analysis of the Belob Trial (A Randomized Phase Ii Study on Bevacizumab versus Bevacizumab plus Lomustine versus Lomustine Single Agent in Recurrent Glioblastoma) and First Radiology Review Results
, Neuro-Oncology 16(Suppl 5): v20-v21 (2014)

At-56 * Treatment of Large Low-Grade Oligodendroglial Tumors with Upfront Procarbazine, Lomustine, and Vincristine Chemotherapy with Long Follow-Up: A Retrospective Cohort Study with Growth Kinetics
, Neuro-Oncology 16(Suppl 5): v21 (2014)

At-57 * Long-Term Clinical Results of Extensive Tumor Removal Followed by Acnu-Based Chemoradiotherapy for 147 Anaplastic Gliomas
, Neuro-Oncology 16(Suppl 5): v21 (2014)

At-58 * Jcog0911 Integra Trial: A Randomized Screening Phase Ii Trial of Chemoradiotherapy with Interferon plus Temozolomide versus Chemoradiotherapy with Temozolomide Alone for Newly-Diagnosed Glioblastoma
, Neuro-Oncology 16(Suppl 5): v21 (2014)

At-59 * High-Dose Mtx-Based Chemotherapy for Primary Cns Lymphoma: With or without Whole Brain Radiotherapy? Final Analysis of G-Pcnsl-Sg-1
, Neuro-Oncology 16(Suppl 5): v21-v22 (2014)

At-06 * a Phase Ii Trial of Tamoxifen and Bortezomib in Patients with Recurrent high Grade Glioma
, Neuro-Oncology 16(Suppl 5): v9 (2014)

At-61 * Dexamethasone Exerts Profound Interference on Treatment Efficacy for Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v22 (2014)

At-62 * Analysis of Survival Concerning the Extent of Surgical Resection in New Glioblastoma Multiforme: A Single-Centre Retrospective Audit
, Neuro-Oncology 16(Suppl 5): v22 (2014)

At-07 * a Phase Ii Study of Lapatinib and Dose-Dense Temozolomide (Tmz) for Adults with Recurrent Ependymoma: Patient Reported Outcomes (Pro) from a Cern Clinical Trial
, Neuro-Oncology 16(Suppl 5): v9 (2014)

At-08 * Radiotherapy with Vs without Temozolomide in Older Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 5): v9 (2014)

At-09 * Bevacizumab and Gliobastoma of the Elderly: A Single-Center Retrospective Analysis
, Neuro-Oncology 16(Suppl 5): v10 (2014)

Ai-01 * Are We using Too Much Bevacizumab in Our Gbm Patients?
, Neuro-Oncology 16(Suppl 5): v1 (2014)

Ai-10 * Distinct Egfr Signaling In Glioblastoma: Wild-Type Egfr Promotes Invasion While EgfrvIii Drives Prototypical Sfk c-Src Activation To Foster Angiogenesis
, Neuro-Oncology 16(Suppl 5): v3 (2014)

Ai-11 * c-Met-Mediated Endothelial-Mesenchymal Transition Drives Glioblastoma Progression And Therapeutic Resistance
, Neuro-Oncology 16(Suppl 5): v3 (2014)

Ai-12 * Id2/Kdr Drives Formation of Pro-Malignant Myeloid Derived Suppressor cells in Glioma
, Neuro-Oncology 16(Suppl 5): v3 (2014)

Ai-13 * Circulating Endothelial Progenitor Cells In Glioblastoma Patients Express Increased Levels Of c-Kit And Scf
, Neuro-Oncology 16(Suppl 5): v3-v4 (2014)

Ai-14 * the Anti Angiogenic and Invasive effects of an Integrin Inhibitor against Bevacizumab-Induced Invasive Glioma
, Neuro-Oncology 16(Suppl 5): v4 (2014)

Ai-15 * Epidermal Growth Factor-Like Module Containing Mucin-Like Hormone Receptor 2 Role in Predicting Survival in Invasive Gliomas
, Neuro-Oncology 16(Suppl 5): v4 (2014)

Ai-16 * Hif-1a Inhibition by RNA Interference Delivered via a Novel Multifunctional Surfactant Attenuates Glioma Growth in an Intracranial Mouse Model
, Neuro-Oncology 16(Suppl 5): v4 (2014)

Ai-17 * Robo2-Slit1 Signaling Implicated in Glioma Invasion
, Neuro-Oncology 16(Suppl 5): v4-v5 (2014)

Ai-18 * Wound Healing Complications in a Series of Brain Tumor Patients on Bevacizumab
, Neuro-Oncology 16(Suppl 5): v5 (2014)

Ai-19 * Chemokine Receptor Cxcr7 is a Functional Receptor for Cxcl12 in Brain Endothelial cells
, Neuro-Oncology 16(Suppl 5): v5 (2014)

Ai-02 * Hypoxia as a Measure of Functional Status of Glioblastoma Vasculature
, Neuro-Oncology 16(Suppl 5): v1 (2014)

Ai-20 * Mechanisms of Resistance to Egfr Inhibition Associated with an Invasive Phenotype
, Neuro-Oncology 16(Suppl 5): v5 (2014)

Ai-21 * Hif-1A Targeting In An Orthotopic Xenograft Model That Recapitulates The Hypoxic Microenvironment Of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v5 (2014)

Ai-22 * Clinical Outcome of Bevacizumab-Treated Patients with Recurrent Malignant Gliomas
, Neuro-Oncology 16(Suppl 5): v5-v6 (2014)

Ai-23 * Periostin Regulates Tumor Resistance to Antiangiogenic Therapy through Emt and Angiogenesis-Related Mechanisms in Glioma Stem cell Models
, Neuro-Oncology 16(Suppl 5): v6 (2014)

Ai-24 * Vegfr Inhibitors Enhance Progression Of Glioblastoma By Upregulating Cxcr4 In A TgfR Signaling-Dependent Manner
, Neuro-Oncology 16(Suppl 5): v6 (2014)

Ai-25 * The Novel c-Met Inhibitor Altiratinib (Dcc-2701) Inhibits Tumor Growth And Invasion In A Bevacizumab Resistant Glioblastoma Mouse Model
, Neuro-Oncology 16(Suppl 5): v6 (2014)

Ai-26 * Overcoming Resistance to Vegf-Blockade by Targeting the Angiopoietin/Tie2 Axis
, Neuro-Oncology 16(Suppl 5): v6-v7 (2014)

Ai-27 * Bkm-120: An Anti-Invasive Candidate for the Treatment of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v7 (2014)

Ai-28 * Recurrent Glioblastomas after Treatment with Bevacizumab
, Neuro-Oncology 16(Suppl 5): v7 (2014)

Ai-29 * Angiogenic Switch from Vegfr2/Hif1 in Newly Diagnosed Glioblastoma (Gb) to Cxcr4-Sdf1 Pathway in Recurrent Paired Tumor after Radiotherapy (Rt)-Temozolomide (Tmz)
, Neuro-Oncology 16(Suppl 5): v7 (2014)

Ai-03 * Targeting Angiogenesis without Increasing the Stromal cell Response or Invasion using Abt-898, a Thrombospondin type 1 Repeat Peptide
, Neuro-Oncology 16(Suppl 5): v1 (2014)

Ai-04 * Mechanisms of Glioma Formation: Perivascular Glioma Invasion is a Vegf-Independent Mechanism of Tumor Vascularization
, Neuro-Oncology 16(Suppl 5): v1-v2 (2014)

Ai-05 * Impact of Gbm Microenvironment on Expression Profile of Bone Marrow Derived Progenitor cells
, Neuro-Oncology 16(Suppl 5): v2 (2014)

Ai-06 * Non-Canonical Nf-kB Signaling Drives The Aggressive Invasiveness Of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v2 (2014)

Ai-07 * Glioblastoma Subtypes do not Exploit Differential Angiogenic Signaling Pathways Nor Are the Vessels Functionally different
, Neuro-Oncology 16(Suppl 5): v2 (2014)

Ai-08 * Subgroup-Specific Deregulation of Coagulation and Angiogenic Gene Expression Profiles in Medulloblastoma- Evidence for Cross-Talk between Growth Factor and Coagulation Pathways
, Neuro-Oncology 16(Suppl 5): v2 (2014)

Ai-09 * Patterns of Salvage Treatment for high Grade Glioma in the Temozolomide Era
, Neuro-Oncology 16(Suppl 5): v3 (2014)

Bi-01 * Blood Serum and C.S.F. Analytes show Potential for Use as a Diagnostic Biomarker for low and high Grade Glioma
, Neuro-Oncology 16(Suppl 5): v23 (2014)

Bi-10 * pH-Weighted Mri In Human Gliomas
, Neuro-Oncology 16(Suppl 5): v25 (2014)

Bi-11 * Prognostic micro Rnas In Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v25 (2014)

Bi-12 * Rtog 0525 Recursive Partitioning Analysis Based on Clinical and Protein Biomarker Parameters
, Neuro-Oncology 16(Suppl 5): v25 (2014)

Bi-13 * Tissue Transglutminase: A Potential Adjuvant Target for Primary Brain Tumor
, Neuro-Oncology 16(Suppl 5): v26 (2014)

Bi-14 * Genomic Profiling of a Predictive Signature for Met-Targeted Therapy in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v26 (2014)

Bi-15 * Radio- Chemotherapy Improves Survival for Idh Mutant, 1p19q-Non-Codeleted Secondary High-Grade-Astrocytoma
, Neuro-Oncology 16(Suppl 5): v26 (2014)

Bi-16 * Circulating Protein Analysis of Potential Brain Tumor Biomarkers
, Neuro-Oncology 16(Suppl 5): v26 (2014)

Bi-17 * Early Cognitive Function tests Predict Early Progression in Newly-Diagnosed Glioblastoma
, Neuro-Oncology 16(Suppl 5): v26-v27 (2014)

Bi-18 * Cellular Microparticles as Blood-Borne Endothelial Biomarkers in Patients with Malignant Gliomas
, Neuro-Oncology 16(Suppl 5): v27 (2014)

Bi-19 * Pseudoprogression in Oligodendrogliomas and Mixed Oligoastrocytomas is Associated with Poor Prognosis
, Neuro-Oncology 16(Suppl 5): v27 (2014)

Bi-02 * Functional Characterization of Novel Biomarkers in Selecting for Subtype Specific Medulloblastoma Phenotypes
, Neuro-Oncology 16(Suppl 5): v23 (2014)

Bi-20 * Genetic Profiling For Early Everolimus Sensitivity In Newly Diagnosed Glioblastoma Patients Enrolled On Ncctg N057K
, Neuro-Oncology 16(Suppl 5): v27 (2014)

Bi-21 * Braf Mutation And Cdkn2A Deletions Define A Clinically Distinct Subgroup Of Childhood Secondary High Grade Glioma
, Neuro-Oncology 16(Suppl 5): v27-v28 (2014)

Bi-22 * Correlation of Molecular Subtypes with Overall Survival (Os) in Avaglio, a Randomized, Placebo-Controlled Study of Bevacizumab (Bev) plus Radiotherapy (Rt) and Temozolomide (Tmz) for Newly Diagnosed Glioblastoma (Gbm)
, Neuro-Oncology 16(Suppl 5): v28 (2014)

Bi-23 * Loss Of Novel lncRna Defines The Glioblastoma Mesenchymal Subtype
, Neuro-Oncology 16(Suppl 5): v28 (2014)

Bi-24 * Collagen Plays a Role in Glioblastoma Tumor Invasion and Patient Survival
, Neuro-Oncology 16(Suppl 5): v28 (2014)

Bi-25 * Circulating Tumor cells in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v28-v29 (2014)

Bi-26 * How Much Insight can a Stereotactic Biopsy Deliver?
, Neuro-Oncology 16(Suppl 5): v29 (2014)

Bi-27 * Analysis of the Biochemical Profile of low Grade Glioma with different Idh1 Mutation Status using Vibrational Spectroscopy
, Neuro-Oncology 16(Suppl 5): v29 (2014)

Bi-28 * New Monocyte Subtyping Distinguishes Glioma Patients from Healthy Controls
, Neuro-Oncology 16(Suppl 5): v29 (2014)

Bi-29 * Variant Analysis of Primary and Recurrent Glioblastoma using Ion Ampliseqtm Comprehensive Cancer Panel and Whole Exome Sequencing
, Neuro-Oncology 16(Suppl 5): v29-v30 (2014)

Bi-03 * Glioblastoma-Specific and Glioblastoma Stem cell Subtype-Specific Signatures of Long, Non-Coding Rnas
, Neuro-Oncology 16(Suppl 5): v23 (2014)

Bi-30 * Characterization Of L1Cam As A Clinical Marker For The C11orf95-Rela Fusion In Supratentorial Ependymomas
, Neuro-Oncology 16(Suppl 5): v30 (2014)

Bi-31 * Analysis and Quantification of Multiple Antigen Expression in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v30 (2014)

Bi-32 * Risk Factor Analysis for Patients with Newly Diagnosed Glioblastoma Who Did not Receive Salvage Therapy
, Neuro-Oncology 16(Suppl 5): v30 (2014)

Bi-33 * Bevacizumab-Induced Hypertension is a Predictive Marker for Improved Outcomes in Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v30-v31 (2014)

Bi-04 * Pre-Operative low Tri-Iodothyronine Syndrome is Associated with Greater 6-Month Mortality Rate of Neurosurgical Brain Tumor Patients
, Neuro-Oncology 16(Suppl 5): v23 (2014)

Bi-05 * Molecular Profiling of low Grade Gliomas (Lgg) in Colombia (Oncolgroup)
, Neuro-Oncology 16(Suppl 5): v24 (2014)

Bi-06 * Atrx Loss in Chinese Adult Diffuse Astrocytomas Correlates with Idh1 and Tp53 Mutation and Predicts Better Outcome in Tp53 Mutated Patients
, Neuro-Oncology 16(Suppl 5): v24 (2014)

Bi-07 * Hyperpolarized [1-13C] Glutamate: A Metabolic Imaging Biomarker Of Idh1 Mutational Status In Glioma
, Neuro-Oncology 16(Suppl 5): v24 (2014)

Bi-08 * Microvesicles can Distinguish between Tumor Progression and Treatment Effect/Pseudoprogression in Glioblastoma Patients Treated with Radiation and Temozolomide
, Neuro-Oncology 16(Suppl 5): v24 (2014)

Bi-09 * EphA3 Receptor Is A Molecular Target Expressed In Multiple Compartments Of Gbm
, Neuro-Oncology 16(Suppl 5): v25 (2014)

Bm-01 * Dosimetric Hotspots Are the Most Powerful Dosimetric Predictor of Local Control in Nsclc Brain Metastases
, Neuro-Oncology 16(Suppl 5): v32 (2014)

Bm-10 * Systemic Treatment and Radiation Necrosis following Gksrs in the Treatment of Brain Metastases
, Neuro-Oncology 16(Suppl 5): v34 (2014)

Bm-11 * Leptomeningeal Metastases in High-Grade Adult Glioma: Development, Diagnosis, Management and Outcomes in a Series of 34 Patients
, Neuro-Oncology 16(Suppl 5): v34 (2014)

Bm-12 * Cerebral Infarction Secondary to Pulmonary Vein Compression and left Atrial Appendage Tumor Infiltration as the Presenting Sign of Metastatic Squamous cell Carcinoma of the Base of the Tongue
, Neuro-Oncology 16(Suppl 5): v34 (2014)

Bm-13 * The (F)Utility Of Predictive Models
, Neuro-Oncology 16(Suppl 5): v34-v35 (2014)

Bm-14 * a Paradigm Shift in Determining Brain Metastasis Treatment: Does Number Really Matter?
, Neuro-Oncology 16(Suppl 5): v35 (2014)

Bm-15 * Targeting Mek is a Novel and Effective Treatment Strategy of Lung Cns Metastasis
, Neuro-Oncology 16(Suppl 5): v35 (2014)

Bm-16 * increased Acute Radiation effect (Are) with Ipilumumab and Radiosurgery in Patients with Melanoma Brain Metastases
, Neuro-Oncology 16(Suppl 5): v35 (2014)

Bm-17 * Final Results of a Randomized Trial to Identify the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases
, Neuro-Oncology 16(Suppl 5): v35 (2014)

Bm-18 * Prolonged Response with Bevacizumab + Navelbine as Third Line of Treatment of Breast Cancer Leptomeningeal Metastases: A Case Report
, Neuro-Oncology 16(Suppl 5): v36 (2014)

Bm-19 * Symptomatic and Economic Burden of Brain Metastases in Patients with Alk+ Nsclc
, Neuro-Oncology 16(Suppl 5): v36 (2014)

Bm-02 * New Disease Specific Graded Prognostic Assessment of Brain Metastasis from Lung, Breast, Melanoma and Renal Malignancies
, Neuro-Oncology 16(Suppl 5): v32 (2014)

Bm-20 * Evaluation of Risk Factors for Death within three Months after Stereotactic Radiosurgery for Brain Metastases
, Neuro-Oncology 16(Suppl 5): v36 (2014)

Bm-21 * Risk of Neoplastic Meningitis from Brain Metastases in Nsclc Initially Treated without Whole Brain Irradiation: A Retrospective Analysis of a Case Series
, Neuro-Oncology 16(Suppl 5): v36 (2014)

Bm-22 * Boc and Map2 Are Operative in Breast Cancer Metastasis to Brain
, Neuro-Oncology 16(Suppl 5): v36-v37 (2014)

Bm-23 * Twist1 Expression Confirms the Role of an Emt-Like Process in Medulloblastoma Metastasis
, Neuro-Oncology 16(Suppl 5): v37 (2014)

Bm-24 * Multi-Gene Methylation Analysis to Identify Signature Genes for Brain Metastasis from Primary Breast Tumors
, Neuro-Oncology 16(Suppl 5): v37 (2014)

Bm-25 * Proneural Transcription Factor Atoh1 Drives Leptomeningeal Metastasis of the Sonic Hedgehog Subgroup of Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v37 (2014)

Bm-26 * Cd15 and E-Selectin Mediation of Adhesion of Non-Small cell Lung Cancer cells to Brain Endothelium in Lung-Brain Metastasis
, Neuro-Oncology 16(Suppl 5): v26 (2014)

Bm-27 * Estimating the Additional Benefit of Surgical Excision to Stereotactic Radiosurgery in the Management of Metastatic Brain Disease
, Neuro-Oncology 16(Suppl 5): v38 (2014)

Bm-28 * Biological Pathways Associated with Breast Cancer Metastasis to the Brain
, Neuro-Oncology 16(Suppl 5): v38 (2014)

Bm-29 * Number of Brain Metastases Influences Survival following Gamma Knife Radiosurgery
, Neuro-Oncology 16(Suppl 5): v38 (2014)

Bm-03 * Revised Graded Prognostic Assessment for Melanoma Patients with Brain Metastasis (Mbm)
, Neuro-Oncology 16(Suppl 5): v32 (2014)

Bm-30 * Intra Cerebropsinal Fluid Concentrations of Vemurafenib in Melanoma
, Neuro-Oncology 16(Suppl 5): v38 (2014)

Bm-31 * Study of Incidence and Estimation of Risk Factors Associated with Hippocampal Metastasis
, Neuro-Oncology 16(Suppl 5): v38-v39 (2014)

Bm-32 * Ceritinib (Ldk378) for Treatment of Patients with Alk-Rearranged (Alk+) Non-Small cell Lung Cancer (Nsclc) and Brain Metastases (Bm) in the Ascend-1 Trial
, Neuro-Oncology 16(Suppl 5): v39 (2014)

Bm-34 * New Uses of Old Drugs for the Clinical Treatment of Brain Metastases
, Neuro-Oncology 16(Suppl 5): v39 (2014)

Bm-35 * Clinical Factors Impacting Survival in Brain Metastases
, Neuro-Oncology 16(Suppl 5): v39 (2014)

Bm-36 * Microenvironment-Dependent Changes To The Mature microRna Expression Profile Of Breast Cancer Cells Metastatic To The Brain
, Neuro-Oncology 16(Suppl 5): v39-v40 (2014)

Bm-37 * Complications Related to the Use of a Ventricular Device for the Treatment of Leptomeningeal Metastases from Solid Tumors: A Single Center Experience on 112 Patients
, Neuro-Oncology 16(Suppl 5): v40 (2014)

Bm-38 * the Preferred Anatomic Distribution of 1172 Brain Metastases Based on Brain Volume and Regional Blood Flow
, Neuro-Oncology 16(Suppl 5): v40 (2014)

Bm-04 * Image Guided Stereotactic Rapid Arc(R) to Single Brain Metastatic Assisted by Intracranial Calcification
, Neuro-Oncology 16(Suppl 5): v32-v33 (2014)

Bm-05 * Ipilumumab Therapy for Melanoma Brain Metastases is Associated with increased Radiation Necrosis
, Neuro-Oncology 16(Suppl 5): v33 (2014)

Bm-06 * Mechanistic Investigations of Leptomeningeal Metastasis from Solid Tumors
, Neuro-Oncology 16(Suppl 5): v33 (2014)

Bm-07 * Genomic Characterization of Brain Metastases Reveals Branched Evolution and Metastasis-Specific Mutations
, Neuro-Oncology 16(Suppl 5): v33 (2014)

Bm-08 * Prognostic Factors for Srs-Treated Patients with Cerebral Metastasis: Implications on Randomized Control Trial Design and Inter-Institutional Collaborative Efforts
, Neuro-Oncology 16(Suppl 5): v33 (2014)

Bm-09 * Use of Neuroendoscopy to Safely Deliver Intrathecal Chemotherapy at the Time of Ommaya Reservoir Placement
, Neuro-Oncology 16(Suppl 5): v34 (2014)

Cb-01 * Targeting Collagen Regulation in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v41 (2014)

Cb-11 * Diverse Roles For RhoA And RhoC In Glioblastoma
, Neuro-Oncology 16(Suppl 5): v43 (2014)

Cb-13 * Phenotypic Changes by Nuclear-Encoded Cytochrome C Oxidase Sub-Unit 4, Isoform 1 Supports Poor Prognostic in Gbm Patients
, Neuro-Oncology 16(Suppl 5): v43 (2014)

Cb-14 * Genomic Approaches to Identify Coding and Noncoding RNA Targets in Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v43 (2014)

Cb-15 * Nkcc1 Regulates Migration Capacity of Glioblastoma Tumor Initiating cells by Modulating Actin Cytoskeleton through small Rho Gtpases
, Neuro-Oncology 16(Suppl 5): v43-v44 (2014)

Cb-16 * Malignant Glioma with Primitive Neuroectodermal Components: Clinical and Pathologic Features of five Cases
, Neuro-Oncology 16(Suppl 5): v44 (2014)

Cb-17 * Characterization of Hcmv-Ecoded Chemokine Receptor Us28 Transduced Msu1.1 Human Fibroblast cells
, Neuro-Oncology 16(Suppl 5): v44 (2014)

Cb-18 * Interrogation of Sub-Clonal Genetic Diversity of Human Gbm Reveals Genetic Heterogeneity in Tumour-Propagating Cells, Which Display Variable Competitive Capacity for Tumour Propagation in Vivo
, Neuro-Oncology 16(Suppl 5): v44 (2014)

Cb-19 * Pid1, a New Growth-Inhibitory Gene, Sensitizes Medulloblastoma and Glioma cell Lines to Chemotherapy
, Neuro-Oncology 16(Suppl 5): v44 (2014)

Cb-20 * Slc39A4 (Zip4) Inhibition Slows Down Gbm Cell Proliferation And Intracranial Tumor Xenograft Growth
, Neuro-Oncology 16(Suppl 5): v45 (2014)

Cb-02 * MiRna Expression Profiles Of Glioma Stem Cells And Their Association With The Mesenchymal Transformation Of These Cells
, Neuro-Oncology 16(Suppl 5): v41 (2014)

Cb-03 * Identification and Characterisation of Micro Rnas Involved in Glioblastoma cell Proliferation and Survival using High-Throughput Screening
, Neuro-Oncology 16(Suppl 5): v41 (2014)

Cb-04 * Epigenetic Regulation of Glioblastoma Tumorigenicity: A Hybrid Model
, Neuro-Oncology 16(Suppl 5): v41 (2014)

Cb-05 * the Role of Emb-5 in Glioblastoma Maintenance and Therapeutic Resistance
, Neuro-Oncology 16(Suppl 5): v42 (2014)

Cb-07 * Distinct Radiation Response of Slow-Dividing Cancer Stem cells
, Neuro-Oncology 16(Suppl 5): v42 (2014)

Cb-08 * Kif3A Is Essential For Ciliogenesis, Cilia Function And Promotes Glioblastoma Progression
, Neuro-Oncology 16(Suppl 5): v42 (2014)

Cb-09 * the cell of Origin for Glioblastoma Contributes to the Phenotypic Heterogeneity of Glioma Stem cells
, Neuro-Oncology 16(Suppl 5): v42 (2014)

Cb-10 * Intraoperative Flow Cytometry Analysis of Glioma Tissue for Rapid Determination of Tumor Presence and its Histopathological Grade
, Neuro-Oncology 16(Suppl 5): v42-v43 (2014)

Cs-01 * the Phosphorylation of Atoh1 Leads to its Degradation Mediated by the E3 Ubiquitin Ligase Huwe1 in Granule Neuron Progenitors
, Neuro-Oncology 16(Suppl 5): v51 (2014)

Cs-10 * Fgfr4 is Expressed in Human Gliomas of different Grades and Histologies
, Neuro-Oncology 16(Suppl 5): v53 (2014)

Cs-11 * an Rnai Kinome Screen of Glioblastoma Stem cells under Normoxia and Hypoxia
, Neuro-Oncology 16(Suppl 5): v53 (2014)

Cs-12 * Transforming Growth Factor- Pathway Activity in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v53 (2014)

Cs-13 * Bone Morphogenetic Protein Signaling Promotes Tumorigenesis in a Transgenic Mouse Model of Glioma
, Neuro-Oncology 16(Suppl 5): v53 (2014)

Cs-14 * Neurotrophin Receptors TrkB And TrkC Are Required For Survival Of Brain Tumor Initiating Cells
, Neuro-Oncology 16(Suppl 5): v54 (2014)

Cs-15 * Nuclear Factor I-A (Nfia) Promotes Gbm Survival Through NfkB Pathway
, Neuro-Oncology 16(Suppl 5): v54 (2014)

Cs-17 * Upregulation Of The Endoplasmic Reticulum Chaperone, Prolyl 4-Hydroxylase, Beta Polypeptide (P4Hb) Promotes Invasion, Angiogenesis And Growth Via Egfr/Mapk (Erk) Signalling Pathway In Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v54 (2014)

Cs-18 * Src Family Kinases Differentially Influence Glioma Growth and Motility
, Neuro-Oncology 16(Suppl 5): v54-v55 (2014)

Cs-19 * Pdgf Signaling Dependence in Proneural Glioblastoma, the Beginning but not the End
, Neuro-Oncology 16(Suppl 5): v55 (2014)

Cs-02 * Shp2 Promotes Tumor Progression in Gbm via Ras Activation
, Neuro-Oncology 16(Suppl 5): v51 (2014)

Cs-20 * Transcriptional Control of the Osmotic Engine by Tead4 Potentiates Invasion and Confers Poor Prognosis in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v55 (2014)

Cs-21 * EphA2 Promotes Infiltrative Invasion Of Glioma Stem Cells In Vivo Through Crosstalk With Akt And Regulates Stem Properties
, Neuro-Oncology 16(Suppl 5): v55 (2014)

Cs-22 * Mixed Lineage Kinase Signaling is Required for Glioblastoma cell Migration and Invasion
, Neuro-Oncology 16(Suppl 5): v55-v56 (2014)

Cs-23 * Defining the Networks and Intersection of Egfr Amplification and Nfkbia Deletion in Human Glioma
, Neuro-Oncology 16(Suppl 5): v56 (2014)

Cs-24 * Pyruvate Kinase M2-Mediated Subcellular Localization Of HuR Regulates Glioma Growth
, Neuro-Oncology 16(Suppl 5): v56 (2014)

Cs-25 * Molecular Subclassification of Glioblastoma Based on the Absolute Quantitative Proteomics
, Neuro-Oncology 16(Suppl 5): v56 (2014)

Cs-26 * Fibulin-3 Regulates Canonical NfkB Signaling In Glioma Cells And Surrounding Stromal Cells To Promote Tumor Invasion
, Neuro-Oncology 16(Suppl 5): v56 (2014)

Cs-27 * Idh1/2 Mutations Influence Zeb1 Expression in Grades Ii and Iii Gliomas
, Neuro-Oncology 16(Suppl 5): v57 (2014)

Cs-28 * the Transcription Factor Pou3f2 Uniformly Express in Human Gliomas and Promotes Tumorigenesis and Overall Growth Rate in Vivo
, Neuro-Oncology 16(Suppl 5): v57 (2014)

Cs-29 * A Kinome-Wide Rnai-Screen In Drosophila Glia And Human Gbm Cells Reveals That Stk17A Drives Neoplastic Glial Cell Proliferation And Invasion
, Neuro-Oncology 16(Suppl 5): v57 (2014)

Cs-03 * Utilizing Collagen and Discoidin Domain Receptor Signaling as a Newtherapeutic Strategy in Human Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v51 (2014)

Cs-30 * Protein Kinase Ck2 is Important for the Function of Glioblastoma Brain Tumor Initiating cells
, Neuro-Oncology 16(Suppl 5): v57 (2014)

Cs-31 * a Novel Yap-Driven Migration and Invasion Signaling Pathway Predicts Poor Outcome in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v57-v58 (2014)

Cs-32 * SapC-Dops Induces Smac-And Bax-Mediated Mitochondrial Apoptosis In Neuroblastomas
, Neuro-Oncology 16(Suppl 5): v58 (2014)

Cs-34 * Evidence for Oligodendrocyte Origins of Pediatric Glioma
, Neuro-Oncology 16(Suppl 5): v58 (2014)

Cs-35 * Tgf- Induces and Bmp Suppresses Vegf Release Depending on Smad2/3 versus Smad1/5/8 Signaling in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v58 (2014)

Cs-36 * IkappaB Zeta Overexpression Drives Human Glioma Resistance To Necroptosis
, Neuro-Oncology 16(Suppl 5): v58-v59 (2014)

Cs-37 * Dual Functions of Efemp1 in Malignant Glioma in Respect to Regulation of Egfr and Notch Signaling Pathways
, Neuro-Oncology 16(Suppl 5): v59 (2014)

Cs-38 * Bai1 is a New Tumor Suppressor in Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v59 (2014)

Cs-04 * Stat3 Involvement in an Emt-Like Process in Glioblastoma Brain Tumor Initiating cells
, Neuro-Oncology 16(Suppl 5): v51 (2014)

Cs-05 * Mutation Specific Functions of Egfr Result in a Mutation-Specific Downstream Pathway Activation
, Neuro-Oncology 16(Suppl 5): v52 (2014)

Cs-06 * Egfr Phosphorylation of Dcbld2 Recruits Traf6 and Stimulates Akt-Promoted Tumorigenesis
, Neuro-Oncology 16(Suppl 5): v52 (2014)

Cs-07 * mTorc2/Akt Signaling Is Modulated By Noncanonical Mitochondrial Notch-Pink1 Interaction In Medulloblastoma (Group Iii) Tumorigenesis
, Neuro-Oncology 16(Suppl 5): v52 (2014)

Cs-08 * Sonic Hedgehog Signaling Protects Atoh1 from Degradation Mediated by the Hect Domain E3 Ubiquitin Ligase Huwe1 in Cerebellar Granule Neuron Progenitors
, Neuro-Oncology 16(Suppl 5): v52 (2014)

Cs-09 * Rtvp-1 Promotes the Mesenchymal Transformation of Glioma Stem cells via the Cxcr4 and Il-6 Pathways
, Neuro-Oncology 16(Suppl 5): v52-v53 (2014)

Cn-01 * Evidence for Active Glycolysis in the White Matter of an Adult Survivor of a Pediatric Brain Tumor with Long-Term Treatment-Related Brain Injury
, Neuro-Oncology 16(Suppl 5): v46 (2014)

Cn-11 * Orteronel (Tak-700) and Posterior Reversible Encephalopathy Syndrome (Pres)
, Neuro-Oncology 16(Suppl 5): v48 (2014)

Cn-12 * Pineal Parenchymal Tumour of Intermediate Differentiation: Case Series from a Single Institute
, Neuro-Oncology 16(Suppl 5): v48 (2014)

Cn-13 * Recurrent Aseptic Meningitis in Patients with Metastatic Brain Tumors; a Novel Perspective
, Neuro-Oncology 16(Suppl 5): v48-v49 (2014)

Cn-14 * Retrospective Analysis of Ischemic Cerebral Strokes in Patients Diagnosed with a Glioblastoma during the Course of a Bevacizumab Treatment
, Neuro-Oncology 16(Suppl 5): v49 (2014)

Cn-15 * Adverse effects of Bevacizumab in Brain Tumor Patients
, Neuro-Oncology 16(Suppl 5): v49 (2014)

Cn-16 * Incidence, Prevalence and Predictors of Chemotherapy induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
, Neuro-Oncology 16(Suppl 5): v49 (2014)

Cn-17 * Impact of Age at Diagnosis on Obesity in Pediatric Brain Tumor Survivors
, Neuro-Oncology 16(Suppl 5): v49 (2014)

Cn-18 * Relationships between Dose Intensity, Toxicity, and Outcome in Oligodendroglial Tumors (Og) Treated with Pcv Regimen
, Neuro-Oncology 16(Suppl 5): v49-v50 (2014)

Cn-19 * Histological Examination of Enhancing Lesion Adjacent to the Implanted Bcnu- Wafers Suggests Vascular Damage as the Major Underlying Mechanism
, Neuro-Oncology 16(Suppl 5): v50 (2014)

Cn-02 * Myelopathy following Intrathecal Chemotherapy: A Case Series in Adults
, Neuro-Oncology 16(Suppl 5): v46 (2014)

Cn-20 * Bevacizumab Causing Recurrent Cerebral Infarction in a Patient with Glioblastoma: A Previously Undocumented Phenomenon
, Neuro-Oncology 16(Suppl 5): v50 (2014)

Cn-21 * Risk Modeling for Temozolomide (Tmz)-Myelotoxicity in Patients with Glioblastoma Treated on Rtog 0825
, Neuro-Oncology 16(Suppl 5): v50 (2014)

Cn-03 * Long-Term Follow-Up Of Endocrine Function Among Young Children With Newly-Diagnosed Malignant Central Nervous System (Cns) Tumors Treated With Irradiation-Avoiding Regimens: The Children'S Hospital Los Angeles (Chla) Experience
, Neuro-Oncology 16(Suppl 5): v46 (2014)

Cn-04 * Treatment of Pediatric Cerebral Radiation Necrosis: A Meta-Analysis
, Neuro-Oncology 16(Suppl 5): v46-v47 (2014)

Cn-05 * do Pediatric Brain Tumor Survivors Suffer an increased Risk of Ovarian/Endocrine Dysfunction as Compared to Non-Brain Tumor Survivors?
, Neuro-Oncology 16(Suppl 5): v47 (2014)

Cn-06 * is Hypopituitarism Clinically Relevant in Glioma Patients? - a Cross-Selectional Trial in Patients with High-Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v47 (2014)

Cn-07 * Predictors of Acute Severe Lymphopenia during Radiotherapy and Temozolomide for High-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v47 (2014)

Cn-08 * Therapeutic Concentration of Temozolomide do not Impair the Function of Human Dendritic cell Subsets
, Neuro-Oncology 16(Suppl 5): v47 (2014)

Cn-09 * Posterior Reversible Encephalopathy Syndrome and Primary Brain Tumors
, Neuro-Oncology 16(Suppl 5): v47-v48 (2014)

Ds-01 * Glucocorticoids Potently Induce Apoptosis in the Cerebellar External Granule Layer: Implications for Medulloblastoma Treatment
, Neuro-Oncology 16(Suppl 5): v65 (2014)

Ds-02 * Induction of Autophagy Markers in Gliomas following Pharmacological Notch Blockade
, Neuro-Oncology 16(Suppl 5): v65 (2014)

Ds-03 * Sonic Hedgehog Antagonists Potently Induce Apoptosis in the Cerebellar External Granule Layer: Implications for Medulloblastoma Treatment
, Neuro-Oncology 16(Suppl 5): v65 (2014)

Ds-04 * Dopamine Addiction in Glioblastoma Multiforme during Chemotherapy is Mediated by a Drd2/-Arrestin/Akt Signaling Complex
, Neuro-Oncology 16(Suppl 5): v65 (2014)

Dn-01 * Bypassing Glioblastoma Resistance to Egfr Inhibitors by Synthetic Lethality
, Neuro-Oncology 16(Suppl 5): v62 (2014)

Dn-03 * Mutant Idh1-Driven Cellular Transformation Increases Rad51-Mediated Homologous Recombination and Temozolomide Resistance
, Neuro-Oncology 16(Suppl 5): v62 (2014)

Dd-01 * Ligand- and Structure-Based Virtual Screening to Discover Polypharmacological Dual Egfr and Brd4 Inhibitors
, Neuro-Oncology 16(Suppl 5): v60 (2014)

Dd-02 * Pharmacodynamic Biomarker Assessments in a Phase I/Ii Trial of the Hypoxia-Activated Prodrug Th-302 and Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v60 (2014)

Dd-03 * the Naturally Occurring Steroid, Withaferin A, in Synergistic Concert with Her2/Egfr Inhibitors Abrogates Proliferation of Human Glioblastoma cell Cultures at Nanomolar Concentrations
, Neuro-Oncology 16(Suppl 5): v60 (2014)

Dd-04 * Penao: A Potent Mitochondrial Targeted Inhibitor for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v60-v61 (2014)

Dd-05 * Gsk3Beta Inhibitory Drugs Attenuate Invasion Of Glioblastoma Cells
, Neuro-Oncology 16(Suppl 5): v61 (2014)

Dd-06 * Potentiating the Therapeutic Efficiency of the Alkylating Chemotherapy Temozolomide in Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 5): v61 (2014)

Dd-07 * a Kinome RNA Interference Screen Identifies Novel Therapeutic Targets for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v61 (2014)

Dd-08 * Phase I Cancer Clinical Trial for 4-Demethyl-4-Cholesteryloxycarbonylpenclomedine (Dm-Choc-Pen)
, Neuro-Oncology 16(Suppl 5): v61 (2014)

P01 * an Unusual Case of a Metastatic Adenocarcinoma of the Prostate into an Intracranial Meningioma
, Neuro-Oncology 16(Suppl 6): vi 1 (2014)

P10 * Correlation between Biologically Effective Dose (Bed) and Local Control of Brain Metastases Post Stereotactic Radiotherapy
, Neuro-Oncology 16(Suppl 6): vi 2 (2014)

P12 * a Phase I Trial of Intravenous Oncolytic Reolysin(R) in Patients with Brain Tumours
, Neuro-Oncology 16(Suppl 6): vi 3 (2014)

P13 * Changing Dose Bandings to Improve Compliance with Temozolomide Concomitant with Radiotherapy for high Grade Glioma; an Analysis of Safety
, Neuro-Oncology 16(Suppl 6): vi 3 (2014)

P14 * Localised Radiation Therapy for Pineal Parenchyma Tumour with Intermediate Differentiation: A Single Institute Experience
, Neuro-Oncology 16(Suppl 6): vi 3 (2014)

P15 * Comparative Outcomes of Bevacizumab and Pcv Chemotherapy in Patients with Recurrent and Progressive Glioblastoma: A Retrospective Study
, Neuro-Oncology 16(Suppl 6): vi 3 (2014)

P17 * Management and Outcomes of Midline Low-Grade Gliomas
, Neuro-Oncology 16(Suppl 6): vi 4 (2014)

P18 * Long Term Survival of high Grade Glioma: A Single Institution Study
, Neuro-Oncology 16(Suppl 6): vi 4 (2014)

P20 * Variations in Management of low Grade Gliomas across Uk Neurosurgical Units
, Neuro-Oncology 16(Suppl 6): vi 4 (2014)

P02 * Primary Central Nervous System Lymphoma (Pcnsl) in the Cerebellum: Report of two Rare Cases and a ten Year Multi-Centre Review of Pcnsl
, Neuro-Oncology 16(Suppl 6): vi 1 (2014 )

P22 * a Retrospective Review of Grade 3 Supratentorial Gliomas with Spinal Metastatic Relapse
, Neuro-Oncology 16(Suppl 6): vi 4-vi 5 (2014)

P23 * Management and Outcome of Adult Medulloblastomas: Are We following Recommended Guidelines?
, Neuro-Oncology 16(Suppl 6): vi 5 (2014)

P24 * a Retrospective Analysis of the Transformation of Low-Grade Gliomas into High-Grade from a Single Institution
, Neuro-Oncology 16(Suppl 6): vi 5 (2014)

P26 * a Management Algorithm for Elderly Patients with high Grade Glioma
, Neuro-Oncology 16(Suppl 6): vi 5 (2014)

P27 * Development of an Implantable Catheter and Bone-Anchored Port for Intermittent Convection-Enhanced Delivery of Carboplatin for Recurrent high Grade Glioma
, Neuro-Oncology 16(Suppl 6): vi 5 (2014)

P31 * Medium-Term Outcome following Interhemispheric Transcallosal Approach for Intraventricular Tumours in Children and Adults
, Neuro-Oncology 16(Suppl 6): vi 6 (2014)

P32 * Increased Percentage Resection Of Tumour Volume Using Neuronavigational 3D Intraoperative Ultrasound: A Single Unit Experience
, Neuro-Oncology 16(Suppl 6): vi 6 (2014)

P03 * Association of Sheltens Scale and Survival in Glioblastoma Patients
, Neuro-Oncology 16(Suppl 6): vi 1 (2014)

P41 * Identification of Glioma Specific Aptamer Targets
, Neuro-Oncology 16(Suppl 6): vi 6-vi 7 (2014)

P43 * Fstl5 Expression is a Marker of Group C in Metastatic Medulloblastomas
, Neuro-Oncology 16(Suppl 6): vi 7 (2014 )

P44 * Clinical Audit: Assessment Of Use And Benefit Of Immunohistochemistry With The Novel Antibody Isocitrate Dehydrogenase 1 (R132H) In Astrocytic Brain Tumour Pathology
, Neuro-Oncology 16(Suppl 6): vi 7 (2014)

P45 * Lipid Signatures in Meningioma - Metabolic Clues to Reveal Potential Therapeutic Targets
, Neuro-Oncology 16(Suppl 6): vi 7 (2014)

P46 * the Ki-67 Labelling Index with Maximally Selected Cut-Offs is Better at Predicting Recurrence than the Who Grading System of Meningiomas
, Neuro-Oncology 16(Suppl 6): vi 7 (2014)

P47 * the Identification of Novel Aptamers to Glioma
, Neuro-Oncology 16(Suppl 6): vi 7-vi 8 (2014)

P48 * Afm Stiffness Measurements of Glioma cells and Cytoskeletal Protein Analysis following Cd44 Knockdown: Implications for Glioma cell Invasion
, Neuro-Oncology 16(Suppl 6): vi 8 (2014)

P50 * Developing a Physiologically Relevant Blood Brain Barrier Model for the Study of Drug Disposition in Glioma
, Neuro-Oncology 16(Suppl 6): vi 8 (2014)

P51 * Preparation of Asiatic Acid Loaded Nanoparticles for Delivery across the Blood Brain Barrier and its effects on Glioblastoma cells in Vitro
, Neuro-Oncology 16(Suppl 6): vi 8 (2014)

P04 * a Rare Case of Primary Cns Angiosarcoma Presenting as an Incomplete Gerstmann Syndrome: A Case Report and Review of Literature
, Neuro-Oncology 16(Suppl 6): vi 1 (2014)

P52 * Targeting Collagen Regulation in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 6): vi 8-vi 9 (2014)

P53 * the Metabolic Autophagy Pathway Regulates the Response to Temozolomide in Glioblastoma Multiforme-Initiating Stem cells
, Neuro-Oncology 16(Suppl 6): vi 9 (2014)

P54 * the Use of Folate to Reduce cell Viability in Glioma cells
, Neuro-Oncology 16(Suppl 6): vi 9 (2014)

P56 * Convection-Enhanced Delivery (Ced) of Carboplatin Nanospheres for the Treatment of Glioblastoma
, Neuro-Oncology 16(Suppl 6): vi 9 (2014)

P57 * Stem cell Plasticity and Tumorigenisis: Regulatory Roles of Heparan Sulphate in the Cancer Stem cell Niche
, Neuro-Oncology 16(Suppl 6): vi 9 (2014)

P58 * Brain Tumour cells can Survive and Thrive in the Hypoxic Solid Tumour Microenvironment
, Neuro-Oncology 16(Suppl 6): vi 9-vi 10 (2014)

P59 * Diagnostic Application of Vibrational Spectroscopy for the Segregation of Brain Tumour cell Lines Coupled with Multivariate Statistics
, Neuro-Oncology 16(Suppl 6): vi 10 (2014)

P60 * Why Animal Models of Gene Therapy Have Let Glioma Patients down
, Neuro-Oncology 16(Suppl 6): vi 10 (2014)

P61 * Cathepsin K in an in Vitro Model of Glioma Angiogenesis
, Neuro-Oncology 16(Suppl 6): vi 10 (2014)

P05 * Variability in Follow up Imaging Guidelines after the Completion of Primary Therapy in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 6): vi 1-vi 2 (2014)

P64 * Quantitative Mgmt Methylation Analysis By Pyrosequencing Reveals A Strong Correlation Between 1P/19Q Co-Deletion And High Level Methylation In High Grade Gliomas
, Neuro-Oncology 16(Suppl 6): vi 10-vi 11 (2014)

P65 * Deregulated Micrornas in Serum as Biomarkers for Glioma
, Neuro-Oncology 16(Suppl 6): vi 11 (2014)

P66 * an Investigation into Substrate effects and Tissue Pre-Processing in Spectral Histopathology using Raman Spectroscopy
, Neuro-Oncology 16(Suppl 6): vi 11 (2014)

P67 * Defining A Target Intra-Cerebrospinal Fluid Steady State Etoposide Concentration [Csf Etoposide] For Phase I Study In Children With Leptomeningeal Metastasis (Lm): Intrepid, A First In Man Study
, Neuro-Oncology 16(Suppl 6): vi 11 (2014)

P69 * Scotin Expression and Survival in Gbm
, Neuro-Oncology 16(Suppl 6): vi 11-vi 12 (2014)

P06 * Supratentorial Pnet in Adults: Mri can Help Distinguish from Glioblastoma - Dwi is Key
, Neuro-Oncology 16(Suppl 6): vi 2 (2014)

P07 * Are All Patients with Suspected Brain Tumour on Cranial Imaging Referred Promptly for Mdt Discussion?
, Neuro-Oncology 16(Suppl 6): vi 2 (2014)

P08 * Intra-Operative Mri: The Alder Hey Experience So Far
, Neuro-Oncology 16(Suppl 6): vi 2 (2014)

P09 * can Rapidarc(R) Improve the Outcome of Gliomas Treated with Radiotherapy?
, Neuro-Oncology 16(Suppl 6): vi 2 (2014)

O01 * a Meta-Analysis of the Diagnostic Ability, Efficacy, Safety and Cost Effectiveness of 5-Aminolevulinic Acid Guided Resection of high Grade Gliomas
, Neuro-Oncology 16(Suppl 6): vi 13 (2014)

O10 * a Novel Polycomb Feed Forward Loop in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 6): vi 14 (2014)

O11 * Transcriptional Profiling of Distinct Compartments in Human Glioblastoma Reveals Key Dysregulated Pathways
, Neuro-Oncology 16(Suppl 6): vi 14-vi 15 (2014)

O12 * Genetic Characterisation Of Pi3K-Related Pathways In Paediatric Gbm In Vitro
, Neuro-Oncology 16(Suppl 6): vi 15 (2014)

O02 * the Incidence and Outcome for Patients with Glioblastoma in England: 2007 - 2011
, Neuro-Oncology 16(Suppl 6): vi 13 (2014)

O03 * Idh1 Mutations in Neural Stem cells Promote Migration and Invasion and Act Synergistically with P53 and Pten Loss in Murine Tumour cells
, Neuro-Oncology 16(Suppl 6): vi 13 (2014)

O04 * Diffusion Weighted Mri Discriminates Primary Cancer type and Outcome in Brain Metastases
, Neuro-Oncology 16(Suppl 6): vi 13 (2014)

O05 * Foxg1 is a Candidate Transcriptional Master Regulator in Neural Stem cells and Glioblastoma
, Neuro-Oncology 16(Suppl 6): vi 13 (2014)

O06 * Targeting Foxm1 as a Novel Therapeutic Strategy for the Treatment of Msh6 Deficient Temozolomide-Resistant Glioblastoma
, Neuro-Oncology 16(Suppl 6): vi 14 (2014)

O07 * Characterising Regional Heterogeneity of Glioblastoma using Multimodal Imaging: Regions of Aggressive Growth
, Neuro-Oncology 16(Suppl 6): vi 14 (2014)

O08 * Haematological Toxicities in Craniospinal Radiotherapy: A 10-Year Review
, Neuro-Oncology 16(Suppl 6): vi 14 (2014)

O09 * Clinical Outcome of 50 Children with Intracranial Ependymoma Treated with Pencil Beam Scanning Proton Therapy
, Neuro-Oncology 16(Suppl 6): vi 14 (2014)

Op01 * Mismatch Repair Deficiency Confers increased Sensitivity to Ionising Radiation (Xr) in Glioblastoma
, Neuro-Oncology 16(Suppl 6): vi 16 (2014)

Op10 * Role of C-Myc in Choroid Plexus Tumours
, Neuro-Oncology 16(Suppl 6): vi 17-vi 18 (2014)

Op11 * Atypical Meningioma: Is Adjuvant Radiotherapy Necessary?
, Neuro-Oncology 16(Suppl 6): vi 18 (2014)

Op12 * Boron Neutron Capture Therapy (Bnct): Optimisation of Boron Uptake and Patient Stratification by Lat1 Improves Biological Targeting with Reduced Radiation Time, and increased Chance of Tumour Control
, Neuro-Oncology 16(Suppl 6): vi 18 (2014)

Op13 * Identification of Genes Epigenetically Deregulated in Brain Metastasis from Primary Breast Tumours
, Neuro-Oncology 16(Suppl 6): vi 18 (2014)

Op14 * Metastasis Inducing Proteins Predict the Invasiveness and Clinical Outcomes of Brain Metastases
, Neuro-Oncology 16(Suppl 6): vi 18 (2014)

Op15 * Lactate Dehydrogenase a (Ldha) and Childhood Medulloblastoma
, Neuro-Oncology 16(Suppl 6): vi 18-vi 19 (2014)

Op16 * Selective Targeting of Glioma with Nucleic Acid Aptamers
, Neuro-Oncology 16(Suppl 6): vi 19 (2014)

Op17 * Microrna Profiling using small Rna-Seq in Paediatric low Grade Gliomas
, Neuro-Oncology 16(Suppl 6): vi 19 (2014)

Op18 * Identification and Characterisation of Micrornas Involved in Glioblastoma cell Proliferation and Survival
, Neuro-Oncology 16(Suppl 6): vi 19 (2014)

Op02 * Thalamic Tumours in Children: Evaluation of Surgical Strategy
, Neuro-Oncology 16(Suppl 6): vi 16 (2014)

Op20 * Blood Serum and Csf Analytes show Potential for Use as a Diagnostic Biomarker for low and high Grade Glioma
, Neuro-Oncology 16(Suppl 6): vi 19-vi 20 (2014)

Op21 * Assessing Associated Symptoms Of Fatigue: Trialling A 'Symptoms Mdm' In Edinburgh For Primary Brain Tumour
, Neuro-Oncology 16(Suppl 6): vi 20 (2014)

Op22 * Social Deprivation Shortens Survival in Patients with high Grade Glioma
, Neuro-Oncology 16(Suppl 6): vi 20 (2014)

Op23 * an Audit to Assess Psychiatric Conditions that Manifest in Patients with High-Grade Brain Tumours during Treatment
, Neuro-Oncology 16(Suppl 6): vi 20 (2014)

Op25 * Time from Referral to First Definitive Treatment of Patients Diagnosed with High-Grade (Who Grade Iii or Iv) Intra-Cranial Glial Tumours at a Regional Neurosurgical Centre
, Neuro-Oncology 16(Suppl 6): vi 20 (2014)

Op27 * Etoposide Pharmacokinetics following Intra-Cerebrospinal Fluid Administration in Patients with Leptomeningeal Metastases
, Neuro-Oncology 16(Suppl 6): vi 20-vi 21 (2014)

Op28 * the Role of Gender in Cns Tumour Incidence and Survival
, Neuro-Oncology 16(Suppl 6): vi 21 (2014)

Op29 * Primary Brain Lymphoma: The Reality for Patients
, Neuro-Oncology 16(Suppl 6): vi 21 (2014)

Op30 * Diagnostic Delay And Survival In High Grade Gliomas - Evidence Of The "Waiting Time Paradox"
, Neuro-Oncology 16(Suppl 6): vi 21 (2014 )

Op31 * the Sound of Science: Developing the Spectral Light Orchestra
, Neuro-Oncology 16(Suppl 6): vi 21 (2014)

Op03 * Border Transition across the Invasive Margin of Glioblastomas do not Provide Measures of Tumour Invasion: A Diffusion Tensor Study
, Neuro-Oncology 16(Suppl 6): vi 16 (2014)

Op32 * a Combined Strategy for the Detection of Braf Fusions in Pilocytic Astrocytoma using Rt-Pcr and Fish
, Neuro-Oncology 16(Suppl 6): vi 21 (2014)

Op33 * Glycogen Synthase Kinase Inhibitors Reduce 3D Migration Of Patient Derived Glioblastoma Multiforme Stem Cells
, Neuro-Oncology 16(Suppl 6): vi 22 (2014)

Op34 * Targeting Rad51 to Radiosensitise Glioblastoma Stem cells
, Neuro-Oncology 16(Suppl 6): vi 22 (2014)

Op36 * Concordance of Patient and Clinician Reported Presenting Symptoms at Initial Neuro-Oncology Assessment
, Neuro-Oncology 16(Suppl 6): vi 22 (2014)

Op37 * Benign Meningioma and Quality of Life: What Influence does Epilepsy Have on Quality of Life?
, Neuro-Oncology 16(Suppl 6): vi 22 (2014)

Op38 * Robot-Assisted Convection-Enhanced Delivery of Carboplatin for Progressive Dipg - a Safety and Feasibility Report of 5 Cases
, Neuro-Oncology 16(Suppl 6): vi 23 (2014)

Op39 * the Role of Early Intra-Operative Mri in Subtotal Resection of Optic-Hypothalamic Gliomas in Children
, Neuro-Oncology 16(Suppl 6): vi 23 (2014)

Op40 * Post-Operative T2 Hyperintensity in Peri Resection Margin following Awake Macroscopic Intragyral Total Resection of low Grade Glioma is not a Reliable Marker of Residual Tumour
, Neuro-Oncology 16(Suppl 6): vi 23 (2014)

Op04 * Quantitative Measurement of Blood Flow in Paediatric Brain Tumours - a Comparative Study of Dynamic Susceptibility Contrast and Multi-Timepoint Arterial Spin Label Imaging
, Neuro-Oncology 16(Suppl 6): vi 16 (2014)

Op05 * Idh-1 Mutated Glioblastomas Exhibit a less Invasive Phenotype with Diffusion Tensor Imaging
, Neuro-Oncology 16(Suppl 6): vi 16-vi 17 (2014)

Op06 * Metabolomic Analysis of Glioblastoma Multiforme upon Arginine Deprivation Treatment
, Neuro-Oncology 16(Suppl 6): vi 17 (2014)

Op07 * the Immunomodulatory effects of Decorin - a Novel Agent for the Treatment of Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 6): vi 17 (2014)

Op08 * Characterisation of Residual cells in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 6): vi 17 (2014)

Op09 * Stereotactic Radiosurgery for Brain Metastases at the Christie at Salford Royal Hospital: Our Two-Year Experience
, Neuro-Oncology 16(Suppl 6): vi 17 (2014)

Dr-01 * Novel Pediatric Ependymoma Models show high Chemotherapy-Resistance and Hyperactivation of Abc-Transporters
, Neuro-Oncology 16(Suppl 5): v63 (2014)

Dr-02 * Temozolomide Sensitizes Glioma Stem Cells To Trail-Induced Apoptosis Through Upregulation Of c-Cbl
, Neuro-Oncology 16(Suppl 5): v63 (2014)

Dr-03 * Mechanisms that Cause Resistance to Egfr Targeted Therapies in Glioma
, Neuro-Oncology 16(Suppl 5): v63 (2014)

Dr-04 * Valproic Acid and Hedgehog Pathway: A Possible Drug Resistance Mechanism in Medulloblastoma?
, Neuro-Oncology 16(Suppl 5): v63-v64 (2014)

Dr-05 * Treatment and Prognosis after Bevacizumab Failure in Recurrent Glioblastoma: The Cleveland Clinic Experience
, Neuro-Oncology 16(Suppl 5): v64 (2014)

Dr-06 * Reactive Oxygen Species Mediate Therapeutic Response and Resistance in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v64 (2014)

Dr-07 * Targeting Egfr-Viii with Dichloroacetate in Temozolomide Resistant Glioblastoma Models
, Neuro-Oncology 16(Suppl 5): v64 (2014)

Dr-08 * Msk1/ -Catenin Signaling Mediates Resistance To Pi3K/mTor Inhibitors In Glioblastoma
, Neuro-Oncology 16(Suppl 5): v64 (2014)

Ed-01 * Medulloblastoma Presenting as an Intracranial Hemorrhage
, Neuro-Oncology 16(Suppl 5): v66 (2014)

Ed-10 * Associations between Maternal and Inherited Genetic Variation in Folate Metabolism Genes and Pediatric Brain Tumors in a high Risk Population: A Pilot Study
, Neuro-Oncology 16(Suppl 5): v68 (2014)

Ed-12 * Widespread Systemic Metastases from Medulloblastoma without Evidence of Active Cns Involvement: A Case Series
, Neuro-Oncology 16(Suppl 5): v68 (2014)

Ed-13 * Posttraumatic Glioma: Literature Review
, Neuro-Oncology 16(Suppl 5): v68-v69 (2014)

Ed-14 * Quality of Life in Adults with Gliomas: Literature Review
, Neuro-Oncology 16(Suppl 5): v69 (2014)

Ed-15 * Long-Term Prophylactic Antiepileptic Drugs Use in Patients with Gliomas: A 7 Year Retrospective Analysis in a Tertiary Care Center
, Neuro-Oncology 16(Suppl 5): v69 (2014)

Ed-16 * Hfe Polymorphisms affect Survival of Brain Tumor Patients
, Neuro-Oncology 16(Suppl 5): v69 (2014)

Ed-17 * Genetic Modulation of Neurocognitive Function and Outcomes in Glioma Patients
, Neuro-Oncology 16(Suppl 5): v69 (2014)

Ed-18 * Primary Intracranial Soft Tissue Sarcoma in Children and Young Adults: Retrospective Analysis - Md Anderson Cancer Center Experience
, Neuro-Oncology 16(Suppl 5): v69-v70 (2014)

Ed-19 * Incidence and Pattern of Secondary Glioblastoma Multiforme at a Tertiary Care Hospital in Pakistan
, Neuro-Oncology 16(Suppl 5): v70 (2014)

Ed-02 * a Seer-Medicare Data Analysis of Elderly Glioblastoma Patients: Treatment Patterns, Outcomes and Cost
, Neuro-Oncology 16(Suppl 5): v66 (2014)

Ed-20 * the Incidence of Pediatric Brain Tumors within the Scott and White Integrated Healthcare Health System
, Neuro-Oncology 16(Suppl 5): v70 (2014)

Ed-22 * Concurrence of Gliomas in Patients with Multiple Sclerosis: Case Report and Literature Review
, Neuro-Oncology 16(Suppl 5): v70 (2014)

Ed-24 * Gangliogliomas in Children- the Md Anderson Cancer Center Experience
, Neuro-Oncology 16(Suppl 5): v71 (2014)

Ed-25 * Socioeconomic Status Modifies the Impact of Race/Ethnicity on Glioblastoma Prognosis
, Neuro-Oncology 16(Suppl 5): v71 (2014)

Ed-26 * Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in a 27-Years Old Patient
, Neuro-Oncology 16(Suppl 5): v71 (2014)

Ed-27 * Clinical Characteristics and Long-Term Outcome in Movement Disorder in Childhood Thalamic Tumors
, Neuro-Oncology 16(Suppl 5): v71-v72 (2014)

Ed-28 * effect of Valproic Acid Exposure on Survival in Low-Grade Glioma Patients: A Retrospective Analysis
, Neuro-Oncology 16(Suppl 5): v72 (2014)

Ed-29 * the Incidence of Adult and Pediatric Intracranial Ependymomas within the Scott and White Integrated Healthcare System
, Neuro-Oncology 16(Suppl 5): v72 (2014)

Ed-03 * the Impact of Valproic Acid Use on high Grade Glioma
, Neuro-Oncology 16(Suppl 5): v66 (2014)

Ed-31 * Recurrent Pilocytic Astrocytoma of the Corpus Callosum in a Patient with Neurofibromatosis type 1
, Neuro-Oncology 16(Suppl 5): v72 (2014)

Ed-32 * Outcomes of Pediatric Brainstem low Grade Gliomas: A Single Institution Series
, Neuro-Oncology 16(Suppl 5): v73 (2014)

Ed-33 * Elderly Patients with Glioblastoma: Should be Treated in a different Way?
, Neuro-Oncology 16(Suppl 5): v73 (2014)

Ed-34 * Identification of Factors in Glioblastoma not Receiving Upfront Radiation Therapy
, Neuro-Oncology 16(Suppl 5): v73 (2014)

Ed-35 * Primary Spinal Cord Melanoma (Pscm): A Case Report and Literature Review
, Neuro-Oncology 16(Suppl 5): v73 (2014)

Ed-36 * Inherited Variants near Terc and Tert Are Associated with Longer Telomeres and increased Glioma Risk: Genome-Wide Association Results from the Ucsf Adult Glioma Study and the Engage Consortium Telomere Group
, Neuro-Oncology 16(Suppl 5): v73-v74 (2014)

Ed-38 * An Updated Analysis Of Patient Registry Data On Novottf-100A Alternating Electric Fields Therapy For Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v74 (2014)

Ed-39 * Ganglioglioma in Children; Identification of Cases at Risk of Death Due to Progression following Initial Surgery
, Neuro-Oncology 16(Suppl 5): v74 (2014)

Ed-05 * Gender and Reproductive Factors in relation to Survival in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v66-v67 (2014)

Ed-06 * Brainstem Gliomas in Adults: Do Adult Diffuse Intrinsic Pontine Gliomas Exist?
, Neuro-Oncology 16(Suppl 5): v67 (2014)

Ed-08 * Insurance Status Influences the Rates of Reportable Quality Metrics in Brain Tumor Patients: A Nationwide Inpatient Sample Study
, Neuro-Oncology 16(Suppl 5): v67 (2014)

Ed-09 * Tancytic Ependymoma: Presentation of a Rare Cystic Disease Variant and Review of Literature
, Neuro-Oncology 16(Suppl 5): v68 (2014)

Eg-01 * Epigenetic Inactivation of Arginine Biosynthesis Pathway in Paediatric high Grade Glioma
, Neuro-Oncology 16(Suppl 5): v75 (2014)

Eg-10 * Long Non-Coding Rnas in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v77 (2014)

Eg-11 * Dysregulation of Mgmt in Glioblastoma: Friend or Foe?
, Neuro-Oncology 16(Suppl 5): v77 (2014)

Eg-13 * Genome-Wide Methylation Analysis Identifies Genomic DNA Demethylation during Malignant Progression of Gliomas
, Neuro-Oncology 16(Suppl 5): v77 (2014)

Eg-14 * Epigenetic Dysregulation Of The HoxA Locus And Other Homeobox Genes Driven By Ink4a/arf Deficiency And Egfrviii
, Neuro-Oncology 16(Suppl 5): v78 (2014)

Eg-15 * the Methylation Status of Mgmt in Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v78 (2014)

Eg-16 * Aberrant Myst4/Brpf1 Signaling Misdirects Regional Neurogenesis Programs, Sustaining Expression of Self-Renewal Genes in Pediatric Brain Cancers
, Neuro-Oncology 16(Suppl 5): v78 (2014)

Eg-17 * Suv420-Mediated Heterochromatin Changes in Pediatric Brain Cancers
, Neuro-Oncology 16(Suppl 5): v78 (2014)

Eg-02 * Correlation of Mgmt Promoter Methylation Status Analysis using 6 Ms-Mlpa Probes and Clinical Response of Temozolomide in Glioblastoma Patients
, Neuro-Oncology 16(Suppl 5): v75 (2014)

Eg-03 * Expression of Prmt5 Correlates with Malignant Grade in Gliomas and Plays a Pivotal Role in Tumor Growth
, Neuro-Oncology 16(Suppl 5): v75 (2014)

Eg-04 * Development of Highly Potent, Selective Bet Bromodomain Inhibitors that Are Cns Penetrant and Effective in Rodent Models of Brain Cancer
, Neuro-Oncology 16(Suppl 5): v75 (2014)

Eg-05 * Combination of Gene Copy Gain and Epigenetic Deregulation Are Associated with the Aberrant Expression of a Stem cell Related Hox-Signature in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v75-v76 (2014)

Eg-06 * Idh1-Mutation-Associated Long Non-Coding RNA Expression Changes in Glioma
, Neuro-Oncology 16(Suppl 5): v76 (2014)

Eg-07 * cell Cycle Signature and Tumor Phylogeny Are Encoded in the Evolutionary Dynamics of DNA Methylation in Glioma
, Neuro-Oncology 16(Suppl 5): v76 (2014)

Eg-08 * Idh Mutations in Gliomas Associated with Enchondromatosis
, Neuro-Oncology 16(Suppl 5): v76 (2014)

Eg-09 * Epigenetic Profiling Reveals A CpG Hypermethylation Phenotype (Cimp) Associated With Worse Progression-Free Survival In Meningioma
, Neuro-Oncology 16(Suppl 5): v76-v77 (2014)

Et-01 * Il-13 Conjugated Quantum Dots for the Identification and Characterization of Glioma Stem Cells, Soluble Receptors and Exosomes Released by Gbm Tumors
, Neuro-Oncology 16(Suppl 5): v79 (2014)

Et-10 * the Synergistic effect of Inhibitor of Inhibitor of Apoptosis Proteins- Lcl161 and Standard Anti-Cancer Agents on Medulloblastoma cells
, Neuro-Oncology 16(Suppl 5): v81 (2014)

Et-11 * Resveratrol Regulates Glioblastoma And Glioblastoma Stem-Like Cells Via Anti-Tumorigenic Akt Dephosphorylation And p53 Activation
, Neuro-Oncology 16(Suppl 5): v81 (2014)

Et-12 * Phase Ii Study of Onartuzumab plus Bevacizumab versus Placebo plus Bevacizumab in Patients with Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v81 (2014)

Et-13 * Retroviral Replicating Vector (Rrv)-Mediated Prodrug Activator Gene Therapy with Codon-Optimized Nitroreductase in Experimental Glioma
, Neuro-Oncology 16(Suppl 5): v81-v82 (2014)

Et-14 * Optimisation of Boronophenylalanine (Bpa) Delivery and Lat1 Expression for the Clinical Application of Boron Neutron Capture Therapy (Bnct) in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v82 (2014)

Et-15 * Application of a Combinatorial Natural Product Therapy for the Treatment of High-Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v82 (2014)

Et-16 * Marizomib (Npi-0052) Activity as a Single Agent in Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v82 (2014)

Et-17 * Transient Fasting Enhances Replication and Therapeutic Activity of Oncolytic Hsv in Glioblastoma Therapy
, Neuro-Oncology 16(Suppl 5): v82-v83 (2014)

Et-18 * Val-083 is a Novel N7 Alkylating Agent that Inhibits the Growth of Glioma Stem and Non-Stem Cultures, Including Temozolomide-Resistant Lines
, Neuro-Oncology 16(Suppl 5): v83 (2014)

Et-19 * a Phase 1 Study Evaluating Abt-414 with Temozolomide (Tmz) or Concurrent Radiotherapy (Rt) and Tmz in Glioblastoma (Gbm)
, Neuro-Oncology 16(Suppl 5): v83 (2014)

Et-02 * Therapeutically Engineered induced Neural Stem cells Are Tumor-Homing and Inhibit Progression of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v79 (2014)

Et-20 * Interfering with Glioblastoma Multiforme Metabolism to Complement Therapeutic effects of Temozolomide
, Neuro-Oncology 16(Suppl 5): v83 (2014)

Et-21 * Combination of Intravenous and Intracerebral Injection of Oncolytic Parvovirus H-1 in a Phase I/Iia Clinical Trial of Patients with Recurrent Glioblastoma Multiforme: Penetration of H-1 Virus across the Blood-Brain Barrier
, Neuro-Oncology 16(Suppl 5): v83-v84 (2014)

Et-22 * Convection-Enhanced Delivery Of The Auger-Electron-Emitter 125I-UdR: A Highly Efficient Therapy In An Orthotopic Glioblastoma Xenograft Model
, Neuro-Oncology 16(Suppl 5): v84 (2014)

Et-23 * Therapeutic Efficacy of Retroviral Replicating Vectors in Human Breast Cancer Cns Metastasis Model
, Neuro-Oncology 16(Suppl 5): v84 (2014)

Et-24 * a Novel Trojan Horse for In-Vivo Sensitivity Testing of Medulloblastoma Therapies
, Neuro-Oncology 16(Suppl 5): v84 (2014)

Et-25 * Therapeutic Modulation of Mdm2 in Neuroblastoma
, Neuro-Oncology 16(Suppl 5): v84-v85 (2014)

Et-26 * Combined Treatment with Abt263 and Gx15-070 Yields a Synergistic Antiproliferative effect in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v85 (2014)

Et-27 * Replication and Spread of Oncolytic Herpes Virus in Glioma Stem cells can be Enhanced by Specific Inhibition of Histone Deacetylase 6
, Neuro-Oncology 16(Suppl 5): v85 (2014)

Et-28 * Combination Therapy with Met Tyrosine Kinase Inhibitor Emd1214063 and Bevacizumab
, Neuro-Oncology 16(Suppl 5): v85 (2014)

Et-29 * an Optimized Oncolytic Adenovirus for Glioma Therapy: Specific Targeting, Efficient Infection, and Restricted Replication in Glioma
, Neuro-Oncology 16(Suppl 5): v85-v86 (2014)

Et-03 * Cavitation-Based Third Ventriculostomy using Mri-Guided Focused Ultrasound
, Neuro-Oncology 16(Suppl 5): v79 (2014)

Et-30 * a Phase I Trial of Azd7451, a Tropomyosin-Receptor Kinase (Trk) Inhibitor, for Adults with Recurrent Glioblastoma Multiforme (Gbm)
, Neuro-Oncology 16(Suppl 5): v86 (2014)

Et-33 * Placenta-Derived Mesenchymal Stem cells and their Secreted Exosomes Inhibit the Self-Renewal and Stemness of Glioma Stem cells in Vitro and in Vivo
, Neuro-Oncology 16(Suppl 5): v86-v87 (2014)

Et-34 * Highly Selective Hsv Virotherapy for Treatment of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v87 (2014)

Et-35 * Pacritinib: A Novel Jak/Stat Inhibitor with Translational Relevance for Gbm
, Neuro-Oncology 16(Suppl 5): v87 (2014)

Et-36 * Hyperthermia Improves the Radiosensitivity of Glioma Stem cells by Inhibition of Akt Signaling
, Neuro-Oncology 16(Suppl 5): v87 (2014)

Et-37 * Efficacy of Intracranial Delivery of Dichloroacetate and Carboplatin via an Lcp Polymer Microcapsule Device in an Experimental Glioma Model
, Neuro-Oncology 16(Suppl 5): v87 (2014)

Et-38 * Brain Penetrating Non-Viral Gene Vectors for Efficient Gene Transfer to Brain Tumors
, Neuro-Oncology 16(Suppl 5): v87-v88 (2014)

Et-39 * Repeated Pharmacological Doses of Ascorbate Protects Tumours from Radiation Damage in an Intracranial Mouse Glioma Model
, Neuro-Oncology 16(Suppl 5): v88 (2014)

Et-04 * Mebendazole is Efficacious in Diverse Medulloblastoma Tumor Models and Inhibits Tumor Angiogenesis
, Neuro-Oncology 16(Suppl 5): v79 (2014)

Et-40 * Oncolytic Virus induced Hmgb1 Secretion and its Impact on Tumor Angiogenesis
, Neuro-Oncology 16(Suppl 5): v88 (2014)

Et-41 * Temozolomide Cytotoxicity is Potentiated by Metabolic Modifications in Glioblastoma Multiforme (Gbm)
, Neuro-Oncology 16(Suppl 5): v88 (2014)

Et-42 * Development of a Novel, Function-Blocking Anti-Fibulin-3 Antibody as Targeted Reagent for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v88 (2014)

Et-45 * Knockdown Of Tnfsf13B Induces Glioma Stem Cell Apoptosis
, Neuro-Oncology 16(Suppl 5): v89 (2014)

Et-46 * Oncolytic Viral Therapy For Malignant Gliomas Using Myxoma Virus Deleted For Anti-Apoptotic M11L Gene
, Neuro-Oncology 16(Suppl 5): v89 (2014)

Et-49 * Anticancer Potential and Mechanism of Action of Mango Ginger (Curcuma Amada Roxb.) Supercrtical Extracts in Human Glioblastoma cell Lines
, Neuro-Oncology 16(Suppl 5): v89 (2014)

Et-50 * Levetiracetam Downregulates O6-Methylguanine DNA Methyltransferase Expression and Sensitizes Temozolomide-Resistant Glioma cells
, Neuro-Oncology 16(Suppl 5): v89-v90 (2014)

Et-51 * Combined Therapy with a Novel Cxcr4 Antagonist and an Anti-Vegf Antibody Impairs the Growth of Gliomas
, Neuro-Oncology 16(Suppl 5): v90 (2014)

Et-52 * Simultaneous Brain Delivery of a three Anti-Cancer Drug Combination via a Peptide Carrier-Mediated Intravenous Injection of the Three-Drug Cocktail
, Neuro-Oncology 16(Suppl 5): v90 (2014)

Et-05 * Intranasal Delivery of Neural Stem cells Loaded with Oncolytic Adenovirus Extends Survival of Mice with Intracranial Glioma
, Neuro-Oncology 16(Suppl 5): v79-v80 (2014)

Et-53 * Ipilimumab for Recurrent Glioblastoma (Gbm)
, Neuro-Oncology 16(Suppl 5): v90 (2014)

Et-54 * Immunotherapy Based on Tumor Transplant Antigen Recognition Emerges as a Promising Strategy for Recurrent Glioblastoma Multiforme (Gbm) Patients
, Neuro-Oncology 16(Suppl 5): v90-v91 (2014)

Et-55 * the Long Term Risk of Tumor Progression Has not Changed over Time for Supratentorial Grade Ii Gliomas and is not Influenced by the Mode of Surgical Treatment
, Neuro-Oncology 16(Suppl 5): v91 (2014)

Et-56 * Sensitization of Glioblastoma cells to Irradiation by Modulating the Glucose Metabolism
, Neuro-Oncology 16(Suppl 5): v91 (2014)

Et-57 * Topoisomerase Ii in Proneural Gliomas, a Modulator of Transcription and a Therapeutic Target
, Neuro-Oncology 16(Suppl 5): v91 (2014)

Et-58 * the Genetically Engineered Clostridium Novyi-Nt is Efficacious in the Treatment of Intracranial Glioblastomas
, Neuro-Oncology 16(Suppl 5): v91-v92 (2014)

Et-59 * Development and Characterization of a Mek1 Inhibitor (Azd6244) Sensitive Childhood Astrocytoma cell Line
, Neuro-Oncology 16(Suppl 5): v92 (2014)

Et-60 * Enhanced Therapeutic Efficacy of Prodrug Activator Gene Therapy with a Non-Lytic Retroviral Replicating Vector (Toca 511) Combined with Radiation Therapy in Experimental Glioma
, Neuro-Oncology 16(Suppl 5): v92 (2014)

Et-61 * Novel Lipid Nanoparticles for the Delivery of Nucleic Acids to Glioblastoma
, Neuro-Oncology 16(Suppl 5): v92 (2014)

Et-62 * Highly Selective Activity of Mdm2 Inhibitor Rg7112 against Mdm2-Amplified/Tp53 Wild-Type Glioblastomas
, Neuro-Oncology 16(Suppl 5): v92-v93 (2014)

Et-06 * Preclinical Testing of the Histone Deacetylase Inhibitor, Panobinostat, in a Genetically Engineered Diffuse Intrinsic Pontine Glioma Mouse Model
, Neuro-Oncology 16(Suppl 5): v80 (2014)

Et-63 * Targeting the Egfr-Stat-Nf-B Axis in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v93 (2014)

Et-64 * Pre-Clinical Assessment of Dissociative Steroids as Dexamethasone Substitute for Treatment in Diffuse Intrinsic Pontine Glioma (Dipg)
, Neuro-Oncology 16(Suppl 5): v93 (2014)

Et-65 * the Ketogenic Diet Reduces Carbonic Anhydrase 9 and Alters the Expression of Proteins Involved with Glioma Growth and Progression in Hypoxic Conditions
, Neuro-Oncology 16(Suppl 5): v93 (2014)

Et-66 * Er-Stress Inducing Drugs Sensitizes Gbm to Temozolomide through Downregulation of Mgmt and Induction of Regulated Necrosis
, Neuro-Oncology 16(Suppl 5): v93 (2014)

Et-67 * Suicide Gene Therapy for Glioma using Multilineage-Defferentiating Stress Enduring (Muse) cells
, Neuro-Oncology 16(Suppl 5): v94 (2014)

Et-68 * Alternating Electric Fields Perturb the Localization of Cytokinetic Furrow Proteins and Cause Aberrant Mitotic Exit
, Neuro-Oncology 16(Suppl 5): v94 (2014)

Et-69 * Specific Wip1 Inhibitor, Cct007093 Abrogate cell Proliferation, Migration and Invasion induced by the Uvc Radiation in Human Glioblastoma cells
, Neuro-Oncology 16(Suppl 5): v94 (2014)

Et-70 * Combination Of oHsv With Integrin 1 Neutralizing Antibody (Os2966) Augments oHsv Therapy
, Neuro-Oncology 16(Suppl 5): v94 (2014)

Et-71 * the Antitumor effects of Withaferin a in Glioblastoma Stem cells
, Neuro-Oncology 16(Suppl 5): v94-v95 (2014)

Et-07 * does Osmotic Blood-Brain Barrier Disruption Allows Efflux Pump Substrates Delivery to the Tumor and Cns?
, Neuro-Oncology 16(Suppl 5): v80 (2014)

Et-08 * Demethylating Therapy Induces Differentation and Therapeutic Response in Idh1 Mutant Malignant Gliomas
, Neuro-Oncology 16(Suppl 5): v80 (2014)

Et-09 * Decoy Oligonucleotide Derived from Mgmt Enhancer Has an Antineoplastic Activity In-Vitro and In-Vivo
, Neuro-Oncology 16(Suppl 5): v80-v81 (2014)

Ge-01 * Molecular And Pathologic Subsets Of Low Grade Gliomas And Glioneuronal Tumors Identified By microRna Profiling
, Neuro-Oncology 16(Suppl 5): v96 (2014)

Ge-10 * Identification of Patients with Recurrent Gbm that Benefit from Bevacizumab
, Neuro-Oncology 16(Suppl 5): v98 (2014)

Ge-11 * the Florida Center for Brain Tumor Research (Fcbtr): Building Infrastructure to Find a Cure
, Neuro-Oncology 16(Suppl 5): v98 (2014)

Ge-12 * Radiographically-Localized Biopsies Reveal Subtype-Specific Patterns in Molecular and Cellular Composition at the Infiltrative Margins of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v98-v99 (2014)

Ge-13 * a Novel Association of Primary Cns Germinoma in a Patient with Nail Patella Syndrome
, Neuro-Oncology 16(Suppl 5): v99 (2014)

Ge-14 * Transcriptomicplasticityis Associated with the Tumor Microenvironment in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v99 (2014)

Ge-15 * Clonal Evolution and Intratumoral Heterogeneity of Low-Grade Glioma Genomes
, Neuro-Oncology 16(Suppl 5): v99 (2014)

Ge-16 * Japanese Pediatric Molecular Neuro-Oncology Group (Jpmng): Establishment of a Nationwide Molecular Diagnostic Network for Pediatric Malignant Brain Tumors in Japan
, Neuro-Oncology 16(Suppl 5): v99-v100 (2014)

Ge-17 * Alteration Of The p53 Pathway And Ancestral Progenitors Are Associated With Tumor Recurrence In Glioblastoma
, Neuro-Oncology 16(Suppl 5): v100 (2014)

Ge-19 * Genomics Guided Therapeutic Approach for the Treatment of Glioblastoma Multiforme (Gbm) using next Generation Sequencing (Ngs) Technologies
, Neuro-Oncology 16(Suppl 5): v100 (2014)

Ge-20 * Genomic Characterization of Breast Cancer Brain Metastases
, Neuro-Oncology 16(Suppl 5): v100 (2014)

Ge-02 * Clinical Targeted Exome-Based Sequencing for Children Diagnosed with Brain Tumors: Initial Results of an Institute-Wide Project on Personalized Medicine
, Neuro-Oncology 16(Suppl 5): v96 (2014)

Ge-21 * Drastic Genomic Divergence of Recurrent Medulloblastoma Invalidates Targeted Therapies Discovered at Diagnosis
, Neuro-Oncology 16(Suppl 5): v100-v101 (2014)

Ge-22 * Immunohistochemical Molecular Expression Profiling for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v101 (2014)

Ge-23 * Enhancer Hijacking Activates Gfi1 Family Oncogenes in Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v101 (2014)

Ge-24 * Characterizing Intratumor Heterogeneity and Tumor Extension in Pediatric Diffuse Intrinsic Pontine Glioma
, Neuro-Oncology 16(Suppl 5): v101 (2014)

Ge-25 * next Generation Copy Number Analysis by Molecular Inversion Profiling - a Helpful Tool in Diagnostics and Prognostification of Tumors of the Cns
, Neuro-Oncology 16(Suppl 5): v101-v102 (2014)

Ge-27 * Therapeutic Implications of Medulloblastoma Subgroups in Children over Age 3: A Single Centre Population Based Experience
, Neuro-Oncology 16(Suppl 5): v102 (2014)

Ge-28 * Integrated Genomics Demonstrate Relative Spatial Homogeneity in Pediatric Brain Tumors
, Neuro-Oncology 16(Suppl 5): v102 (2014)

Ge-29 * Expression Subclass Profile in Pseudoprogression and True Progression in Newly Diagnosed Gbm
, Neuro-Oncology 16(Suppl 5): v102-v103 (2014)

Ge-30 * Oligoastrocytoma does not Exist: In-Situ Molecular Genetics Favors Classification as Either Oligodendroglioma or Astrocytoma
, Neuro-Oncology 16(Suppl 5): v103 (2014)

Ge-03 * Genomic Characterization of Survival Outliers in Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v96 (2014)

Ge-31 * Deconstructing Tumor Heterogeneity through Differential Gene Coexpression Analysis of Serial Sections (Dgcass)
, Neuro-Oncology 16(Suppl 5): v103 (2014)

Ge-32 * an Intergraded Bioinformatics Approach for Identifying Novel Gene Networks in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v103 (2014)

Ge-33 * a Comprehensive Assessment of Viral Transcripts in Dna- and Rna-Seq Datasets from High-Grade Gliomas Reveals no Association
, Neuro-Oncology 16(Suppl 5): v103 (2014)

Ge-34 * the Mutational Landscape and Temporal and Spatial Clonal Evolution to Progression in 351 Low-Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v103-v104 (2014)

Ge-35 * the Therapeutic Changes of Atypical Teratoid/Rhabdoid Tumor in Molecular Characters
, Neuro-Oncology 16(Suppl 5): v104 (2014)

Ge-36 * Molecular-Genetic And Clinical Characteristics Of The "Astrocytic" Gliomas With Total 1p19q Loss
, Neuro-Oncology 16(Suppl 5): v104 (2014)

Ge-37 * Integrated Genomic Analysis of low Grade Glioma and Glioblastoma Reveals Molecular Stratification by Idh Status across Grades and Histologies
, Neuro-Oncology 16(Suppl 5): v104 (2014)

Ge-38 * Identifying the Treatment-Resistant Mesenchymal Signature by Comparative Analyses between Glioma Sphere-Forming cells and their Glioblastomas of Origin
, Neuro-Oncology 16(Suppl 5): v104-v105 (2014)

Ge-39 * Validation of Glioma Sphere-Forming cells as Models of Glioblastoma and Identification of Novel Drivers of Tumorigenesis through Comprehensive Genomic Characterization
, Neuro-Oncology 16(Suppl 5): v105 (2014)

Ge-40 * Comparative Genomic Analyses Identifies Non-Silent Mutations Present in Both Murine and Human Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v105 (2014)

Ge-04 * Mgmt Methylation is a Positive Prognostic Marker in Patients with Anaplastic Astrocytoma Treated with Concurrent Temozolomide and Radiation
, Neuro-Oncology 16(Suppl 5): v96-v97 (2014)

Ge-41 * Comprehensive and Integrative Genomic Characterization of Diffuse Lower Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v105 (2014)

Ge-42 * Integrated Radiographic and Phylogenetic Case Study of a Primary and Contralateral Recurrent Glioma
, Neuro-Oncology 16(Suppl 5): v105-v106 (2014)

Ge-05 * Exome Sequencing Reveals Braf Mutations in Papillary Craniopharyngiomas
, Neuro-Oncology 16(Suppl 5): v97 (2014)

Ge-06 * Prognostic Significance of Relative 1p19q Codeletion in Oligodendroglial Tumors
, Neuro-Oncology 16(Suppl 5): v97 (2014)

Ge-07 * the Genomic Landscape of Diverse Brain Tumors Reveals Known and Novel Oncogenic Alterations Frequently Associated with Sensitivity to Targeted Inhibitors
, Neuro-Oncology 16(Suppl 5): v97 (2014)

Ge-08 * Targeted next Generation Sequencing of Archival Ffpe Samples from Eortc Study 26951 Shows Strong Prognostic Value of a Molecular Classification in Locally Diagnosed Grade Iii Oligodendroglioma
, Neuro-Oncology 16(Suppl 5): v97 (2014)

Ge-09 * Tert Promoter Mutation, Idh Mutation and 1p/19q Codeletion Define five Glioma Molecular Groups with Specific Clinical Characteristics and Germline Variant Associations
, Neuro-Oncology 16(Suppl 5): v98 (2014)

Ib-01 * Glioma-Derived Galectin-1 is a Potent Suppressor of Nk Immunosurveillance
, Neuro-Oncology 16(Suppl 5): v107 (2014)

Ib-10 * a Duality of Roles for Perforin in Cd8+ T Cell- Glioma Interactions: Contributions to Cytotoxicity and Altered Vascular Permeability
, Neuro-Oncology 16(Suppl 5): v109 (2014)

Ib-11 * Pseudo-Progression (PsdPg) Is A Harbinger Of A More Effective Anti-Tumor Response
, Neuro-Oncology 16(Suppl 5): v109 (2014)

Ib-12 * Lung Mass and Immunosuppressant Responsive Seizures: Vgkc Autoimmunity Masquerading as Etiology or Acting as Reactive Marker?
, Neuro-Oncology 16(Suppl 5): v109 (2014)

Ib-13 * Differences in the Expression of Cd184, Cd95, Cd178 and Cd40 in Human Gliomas of Various Grades, before and after Chemotherapy
, Neuro-Oncology 16(Suppl 5): v109 (2014)

Ib-02 * Role of Tumor Infiltrating Lymphocytes and Pdl1 Expression in Glioblastoma (Gbm) and Brain Metastases (Bm): Comparative Analysis
, Neuro-Oncology 16(Suppl 5): v107 ( 2014)

Ib-03 * Idh Mutant Gliomas Are Resistant to Natural Killer Cell-Mediated Cytolysis
, Neuro-Oncology 16(Suppl 5): v107 (2014)

Ib-04 * Expression of Rage by Tumor Macrophages Promotes Angiogenesis in Gliomas
, Neuro-Oncology 16(Suppl 5): v107 (2014)

Ib-05 * Tumor-Processed Osteopontin/Spp1 Shapes Microglia Polarization and Immune Microenvironment of Glioma
, Neuro-Oncology 16(Suppl 5): v107-v108 (2014)

Ib-06 * the Role of Tgf in Nk Cell-Mediated Cytotoxicity in Medulloblastoma
, Neuro-Oncology 16(Suppl 5): v108 (2014)

Ib-07 * Histoplasmosis with Cns Involvement: Case Presentation with Discussion and Literature Review
, Neuro-Oncology 16(Suppl 5): v108 (2014)

Ib-08 * Computational Imaging Features Derived from Mri Images of the Brain can Discriminate Immune Signature Status in Glioblastoma Multiforme (Gbm)
, Neuro-Oncology 16(Suppl 5): v108 (2014)

Ib-09 * Sting Agonist Induces Potent Anti-Glioma Immunity via Induction of Type-I Ifn Signals in the Tumor Microenvironment
, Neuro-Oncology 16(Suppl 5): v108 (2014)

It-01 * Pd1/Pdl1 Interactions Mediate Suppression of Anti-Tumor Immune Activity in Glioma
, Neuro-Oncology 16(Suppl 5): v110 (2014)

It-13 * Ipilimumab for Recurrent High-Grade Glioma: A Single-Institution Case Series
, Neuro-Oncology 16(Suppl 5): v112 (2014)

It-14 * Mesenchymal Glioma Stem cell Express Icosl
, Neuro-Oncology 16(Suppl 5): v112 (2014)

It-15 * Delta-24-Rgdox: Targeting Co-Stimulatory Immune Checkpoint Proteins with Oncolytic Adenoviruses
, Neuro-Oncology 16(Suppl 5): v112 (2014)

It-16 * Combination Treatment with Delta24-Rgd and Temozolomide Improves Survival and Affects Intratumoral Immune cell Subsets in a Murine Malignant Glioma Model
, Neuro-Oncology 16(Suppl 5): v112-v113 (2014)

It-17 * Ono-Ae3-208 Inhibits Myeloid-Derived Suppressor cells and Glioma Growth
, Neuro-Oncology 16(Suppl 5): v113 (2014)

It-19 * Temozolamide Resistant Innate Lymphocytes Administered during Chemotherapy Improve Survival in High-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v113 (2014)

It-20 * Overexpression Of Il13Ra2: Assessment Of Pro-Aggressive And Pro-Invasive Phenotypes Of Malignant Glioma In A Syngeneic Animal Model
, Neuro-Oncology 16(Suppl 5): v113-v114 (2014)

It-21 * Pd-1 Blockade Shows Synergistic Survival, Anti-Tumor Immune Response and Long-Term Memory with Interstitial but not Systemic Chemotherapy: Study in a Murine Glioblastoma Model
, Neuro-Oncology 16(Suppl 5): v114 (2014)

It-22 * Targeting The Immune Checkpoint Network With miR-138 Exerts Therapeutic Efficacy In Murine Models Of Glioma
, Neuro-Oncology 16(Suppl 5): v114 (2014)

It-25 * Developmentally Regulated Antigens for Immunologic Targeting of Medulloblastoma Subtypes
, Neuro-Oncology 16(Suppl 5): v115 (2014)

It-26 * Identification of Pseudo-Progression in New Diagnosed Glioblastoma (Gbm) in a Randomized Phase 2 of Ict-107: Mri and Pathology Correlation
, Neuro-Oncology 16(Suppl 5): v115 (2014)

It-27 * Oncolytic Adenoviruses-Mediated Immune Responses in Syngeneic Murine Glioma Model
, Neuro-Oncology 16(Suppl 5): v115 (2014)

It-29 * Immune Checkpoint Blockade for Glioblastoma: Preclinical Activity of Single Agent and Combinatorial Therapy
, Neuro-Oncology 16(Suppl 5): v116 (2014)

It-31 * Harnessing the Immunologic Capacity of the Liver against Glioblastoma Multiforme
, Neuro-Oncology 16(Suppl 5): v116 (2014)

It-03 * Adoptive Transfer Of Il13R2-Specific T Cells For The Treatment Of Glioblastoma: Building On Clinical Achievements With Second-Generation Cars
, Neuro-Oncology 16(Suppl 5): v110 (2014)

It-32 * Divergence of Intratumoral and Systemic T cell Repertoires Reflects Local Monocyte Profiles during Glioma Progression
, Neuro-Oncology 16(Suppl 5): v116-v117 (2014)

It-33 * Use of Ifn-Alpha and Poly-Iclc as Chemokine Modulators for Immunotherapy in Gliomas
, Neuro-Oncology 16(Suppl 5): v117 (2014)

It-34 * Pilot Study of Combination of Antitumor Immunotherapy Targeted against Cytomegalovirus (Cmv) plus Regulatory T-Cell Inhibition in Patients with Newly-Diagnosed Glioblastoma Multiforme (Gbm)
, Neuro-Oncology 16(Suppl 5): v117 (2014)

It-36 * Phase 1/2 Study of the Combination of Indoximod and Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors
, Neuro-Oncology 16(Suppl 5): v117-v118 (2014)

It-05 * Administration of Toca 511 to Subjects with Recurrent Hgg Undergoing Repeat Resection
, Neuro-Oncology 16(Suppl 5): v110-v111 (2014)

It-06 * Personalized Immunotherapy for the Treatment of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v111 (2014)

It-10 * Synergistic Cellular Interactions in Adoptive Immunotherapy Leads to Immunologic Rejection of Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v111 (2014)

Ll-01 * The Relationship Between B2M And Cns Lymphoma
, Neuro-Oncology 16(Suppl 5): v119 (2014)

Ll-02 * Temozolomide in Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (Cns-Ptld): A Case Series
, Neuro-Oncology 16(Suppl 5): v119 (2014)

Ll-03 * Stereotactic Radiosurgery for Salvage Treatment of Recurrent Cns Lymphoma
, Neuro-Oncology 16(Suppl 5): v119 (2014)

Ms-01 * Development of Malignant Peripheral Nerve Tumor Model for Evaluating a Tumor Targeted Liposome-Based Therapy
, Neuro-Oncology 16(Suppl 5): v127 (2014)

Ms-11 * Clear cell Petro-Clival Meningioma in a five Year Old Child - Histopathological Diagnosis and Long-Term Clinical Follow-Up
, Neuro-Oncology 16(Suppl 5): v129 (2014)

Ms-12 * Temozolomide-Based Therapy for the Management of Progressive Pituitary Carcinoma
, Neuro-Oncology 16(Suppl 5): v129 (2014)

Ms-13 * Non-Contiguous Leptomeningeal Metastasis of Olfactory Neuroblastomas: A Long-Term Multi-Institutional Experience
, Neuro-Oncology 16(Suppl 5): v129 (2014)

Ms-14 * Patients with Recurrent Atypical Meningioma after Upfront Surgical Resection Salvaged with Radiosurgery Require more Salvage Procedures than Patients Salvaged with Conventional Radiation
, Neuro-Oncology 16(Suppl 5): v129 (2014)

Ms-15 * the Impact of Histopathologic and Radiologic Characteristics in Clinical Outcome of Patients Who Underwent Surgery for Intracranial Meningiomas
, Neuro-Oncology 16(Suppl 5): v129-v130 (2014)

Ms-16 * a Rare Case of Primary Cns Angiosarcoma Presenting as an Incomplete Gerstmann Syndrome: A Case Report and Review of Literature
, Neuro-Oncology 16(Suppl 5): v130 (2014)

Ms-17 * Primary Leptomeningeal Primitive Neuroectodermal Tumor
, Neuro-Oncology 16(Suppl 5): v130 (2014)

Ms-18 * Predictors of Response and Adverse Events for Meningiomas Managed with Gamma Knife Radiosurgery
, Neuro-Oncology 16(Suppl 5): v130 (2014)

Ms-19 * Long-Term Outcomes for Patients with Intracranial Meningiomas: A Single-Institution Retrospective Analysis
, Neuro-Oncology 16(Suppl 5): v130-v131 (2014)

Ms-20 * Leptomeningeal Dissemination in Relapsed Adult Medulloblastoma: Patterns of Disease and Role of Intrathecal Chemotherapy
, Neuro-Oncology 16(Suppl 5): v131 (2014)

Ms-02 * Transcriptome Analysis Identifies The Pi3K/Akt/mTor Pathway As A Targetable Pathway In Schwannoma
, Neuro-Oncology 16(Suppl 5): v127 (2014)

Ms-21 * Subependymomas Demonstrate Lineage Markers Suggesting an Origin within Multipotential Progenitors of the Subventricular Zone
, Neuro-Oncology 16(Suppl 5): v131 (2014)

Ms-22 * Neoplastic Meningitis from Ependymomas of the Adult: A Retrospective Analysis
, Neuro-Oncology 16(Suppl 5): v131 (2014)

Ms-23 * Improving Forward Infusion Pressure in Vascular Brain Tumors using a Double Catheter and Coil Technique
, Neuro-Oncology 16(Suppl 5): v131 (2014)

Ms-24 * Systemic Treatment of Meningiomas: Is There a Role for Long-Acting Somatostatin?
, Neuro-Oncology 16(Suppl 5): v131-v132 (2014)

Ms-25 * Gamma Knife Radiosurgery for Vestibular Schwannoma: Assessment of Quality and Outcomes
, Neuro-Oncology 16(Suppl 5): v132 (2014)

Ms-26 * Extra Cranial Metastasis in a Case of Cerebral Meningioma: A Rare Case Report
, Neuro-Oncology 16(Suppl 5): v132 (2014)

Ms-27 * the Impact of Hypofractionated Linac-Based Stereotactic Radiosurgery upon Early Auditory Functions in the Treatment of Vestibular Schwannomas
, Neuro-Oncology 16(Suppl 5): v132 (2014)

Ms-29 * Sorafenib and Regorafenib Inhibit Growth and Migration of Meningioma cells
, Neuro-Oncology 16(Suppl 5): v132 (2014)

Ms-30 * Meningeal Melanocytoma with Multifocality, Rapid Cns Seeding, and Systemic Metastases
, Neuro-Oncology 16(Suppl 5): v133 (2014)

Ms-31 * Intracranial Meningiomas Complicated by Hypertension: Four Case Reports
, Neuro-Oncology 16(Suppl 5): v133 (2014)

Ms-04 * a Novel Minimally Invasive Approach for the Resection of Intraventricular Tumors
, Neuro-Oncology 16(Suppl 5): v127 (2014)

Ms-05 * Utilizing a Virtual Reality Simulator, Neurotouch, to Determine Proficiency Performance Benchmarks for Resection of Simulated Brain Tumors
, Neuro-Oncology 16(Suppl 5): v127-v128 (2014)

Ms-06 * Defining the Optimal Follow-Up Schedule following Surgical Resection of Grade I Meningioma
, Neuro-Oncology 16(Suppl 5): v128 (2014)

Ms-07 * Meningioma of the Pediatric Skull Base: A Review
, Neuro-Oncology 16(Suppl 5): v128 (2014)

Ms-08 * Gliosarcoma: Features and Outcomes in a Tertiary Care Hospital in Pakistan
, Neuro-Oncology 16(Suppl 5): v128 (2014)

Ms-09 * Prognostic Implications of Histological Clear cells in high Grade Intracranial Ependymal Tumors: A Retrospective Analysis from a Tertiary Care Hospital in Pakistan
, Neuro-Oncology 16(Suppl 5): v128 (2014)

Ms-10 * Clear cell Ependymoma: A Rare Variant First Time Reported by a Tertiary Care Hospital in Pakistan
, Neuro-Oncology 16(Suppl 5): v128 (2014)

Me-01 * Glioma cell Adhesion and Invasion Regulated by Proinflammatory Cytokine in a Novel Surface/Matrix Culture System
, Neuro-Oncology 16(Suppl 5): v120 (2014)

Me-11 * Reduction Of NfkB In The In The Tumor Microenvironment Alters The Neural Extracellular Matrix And Reduces Glioblastoma Growth And Dispersion
, Neuro-Oncology 16(Suppl 5): v122 (2014)

Me-12 * the Tumor Suppressor Lrig1 is Downregulated by Hypoxia and Regulates Glioblastoma cell Invasion
, Neuro-Oncology 16(Suppl 5): v122 (2014)

Me-13 * Loss of Socs3 in Myeloid cells Delays Tumor Growth and Prolongs Survival in a Syngeneic Model of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v122 (2014)

Me-14 * Pro-Migratory and -Proliferative effects of Astrocytes on Gbm cells
, Neuro-Oncology 16(Suppl 5): v122-v123 (2014)

Me-15 * Interaction between Cancer Stem cells and Myeloid Derived Suppressor cells Drives Immunosuppression and Glioblastoma Growth
, Neuro-Oncology 16(Suppl 5): v123 (2014)

Me-16 * is Aquaporin4 (Aqp4) Involved in Adult Human Medulloblastoma Dissemination or in a Beneficial Barrier Formation?
, Neuro-Oncology 16(Suppl 5): v123 (2014)

Me-17 * Jak 1/2 Inhibition following Bone Marrow Transplantation Mitigates Cd11b + /Gr1+ Mediated Low-Grade Glioma Neoangiogenesis
, Neuro-Oncology 16(Suppl 5): v123 (2014)

Me-18 * Induction of M2 type Macrophages by Gbm cells
, Neuro-Oncology 16(Suppl 5): v123 (2014)

Me-20 * Culture of Human Gbm cells on Ecm-Mimicking Chitosan-Hyaluronic Acid Scaffolds Increases Malignancy and Drug Resistance
, Neuro-Oncology 16(Suppl 5): v124 (2014)

Me-03 * Bone Marrow Derived Microglia and their Function within Tumor Microenvironment
, Neuro-Oncology 16(Suppl 5): v120 (2014)

Me-04 * Subventricular Spread of Diffuse Intrinsic Pontine Glioma
, Neuro-Oncology 16(Suppl 5): v120 (2014)

Me-05 * Counterattacking the Force behind Glioma Invasion
, Neuro-Oncology 16(Suppl 5): v120 (2014)

Me-06 * Endogenous Neural Precursor cells Induce cell Death of High-Grade Astrocytomas and Have a Tropism to Tumors in the Human Brain
, Neuro-Oncology 16(Suppl 5): v121 (2014)

Me-07 * Influence of Regional Microenviroment and Astrocyte Heterogeneity on Astrocytoma Development
, Neuro-Oncology 16(Suppl 5): v121 (2014)

Me-08 * Neurons Promote Glioma Growth in an Activity-Dependent Manner
, Neuro-Oncology 16(Suppl 5): v121 (2014)

Me-09 * Dynamic Evidence of Tumor induced Microglia Activation at the Infiltrative Margins of Glioma
, Neuro-Oncology 16(Suppl 5): v121 (2014)

Me-10 * Tumor Microenvironment Infiltrating Myeloid Derived Suppressor cells Inhibit Anti-Tumor T cell Responses
, Neuro-Oncology 16(Suppl 5): v121-v122 (2014)

Mr-01 * MicroRna-145 Regulates Jam-A Expression And Compromises Glioblastoma Maintenance
, Neuro-Oncology 16(Suppl 5): v125 (2014)

Mr-02 * A Genome-Wide miRna Screen Revealed Mir-603 As A Mgmt-Regulating miRna In Glioblastomas
, Neuro-Oncology 16(Suppl 5): v125 (2014)

Mr-03 * MicroRna Profile Of Migrating Glioblastoma Cells Kept In Stem Cell Medium
, Neuro-Oncology 16(Suppl 5): v125 (2014)

Mr-04 * Dicer Regulates Glioma Stem cell State
, Neuro-Oncology 16(Suppl 5): v125 (2014)

Mr-05 * Glioma Stem Cell Specific microRna-mRna Interaction Network
, Neuro-Oncology 16(Suppl 5): v126 (2014)

Mr-06 * MicroRna Signature Associated With Poor Outcome Of Glioblastoma Patients
, Neuro-Oncology 16(Suppl 5): v126 (2014)

Nc-01 * Attentional and Language Functioning in Adult Patients with Glioma: A Voxel-Based Lesion-Symptom Mapping Study
, Neuro-Oncology 16(Suppl 5): v134 (2014)

Nc-10 * Training the Brain to Repair Itself: An Exercise Trial in Pediatric Brain Tumor Survivors
, Neuro-Oncology 16(Suppl 5): v136 (2014)

Nc-11 * Computerized Testing in Patients with Meningiomas: Improvement of Cognitive Functioning after Surgery
, Neuro-Oncology 16(Suppl 5): v136 (2014)

Nc-12 * Depression and Executive Functioning in relation to Survival among Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 5): v136 (2014)

Nc-13 * Cranial Radiation Encompassing the Genu is Associated with Neuro-Psychological Sequelae in Children: A Prospective Study of Diffusion Tensor Imaging (Dti) and Proton Mr Spectroscopy (Mrs)
, Neuro-Oncology 16(Suppl 5): v137 (2014)

Nc-14 * Speech Maps Generated By nTms And Correlation With Direct Intraoperative Electrical Stimulation
, Neuro-Oncology 16(Suppl 5): v137 (2014)

Nc-15 * Relationships between Neurocognitive Functioning and Idh1 Genetic Mutation Status in Malignant Astrocytoma
, Neuro-Oncology 16(Suppl 5): v137 (2014)

Nc-16 * Predictors of Post-Surgical Quality of Life in Patients with Non-Functional Pituitary Adenoma: The Influence of Neurobehavioral Functions
, Neuro-Oncology 16(Suppl 5): v137 (2014)

Nc-02 * Improvements in Neurocognitive Functions and Quality of Life in Patients with Gliomas after Awake Craniotomy
, Neuro-Oncology 16(Suppl 5): v134 (2014)

Nc-03 * Polymorphisms in the Comt, Bdnf and Dtnbp1 Genes and Cognitive Functions in Patients with Brain Tumors
, Neuro-Oncology 16(Suppl 5): v134 (2014)

Nc-04 * the Course of Qol and Neurocognition in Newly Diagnosed Patients with Gbm
, Neuro-Oncology 16(Suppl 5): v134 (2014)

Nc-05 * Association of Neurocognitive and Patient Reported Outcomes with the Presence of Residual Disease following Surgical Resection in Glioblastoma (Gbm)
, Neuro-Oncology 16(Suppl 5): v135 (2014)

Nc-06 * Awake Craniotomy to Maximize Glioma Resection: Methods and Technical Nuances
, Neuro-Oncology 16(Suppl 5): v135 (2014)

Nc-07 * Correlation of Mr Spectroscopy Image of Hippocampus Region and Impairment of Neurocognitive Functions in Patients after Whole Brain Radiotherapy - Preliminary Data
, Neuro-Oncology 16(Suppl 5): v135 (2014)

Nc-08 * Predictors of Survival after Second Surgery for Recurrent Glioblastoma Multiforme Tumours
, Neuro-Oncology 16(Suppl 5): v135-v136 (2014)

Nc-09 * the Impact of Supratotal Resection for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v136 (2014)

Ni-01 * Gene Profiles In High Uptake Area On Positron Emission Tomography With A Hypoxic Cell Tracer, 18F-Frp170
, Neuro-Oncology 16(Suppl 5): v138 (2014)

Ni-10 * a Mass Spectrometry Imaging Platform to Study Drug-Susceptibility of Brain Tumors
, Neuro-Oncology 16(Suppl 5): v140 (2014)

Ni-11 * The Potential Role Of 18F-Fdopa Pet Imaging In The Evaluation Of Low-Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v140 (2014)

Ni-13 * Resolving the Challenges of Peritumoral Edema in Tracing Arcuate Fasciculus for Surgical Planning using Two-Tensor Unscented Kalman Filter Tractography
, Neuro-Oncology 16(Suppl 5): v140 (2014)

Ni-14 * the Diffusion Weighted Imaging Derived Inflection B-Value as a Potential Marker for Brain Tumor Heterogeneity
, Neuro-Oncology 16(Suppl 5): v140 (2014)

Ni-17 * Multimodal Navigated Skull Base Tumor Resection using Image-Based Vascular and Cranial Nerve Segmentation: A Prospective Validation Study
, Neuro-Oncology 16(Suppl 5): v141 (2014)

Ni-18 * Multimodal Navigation in Endoscopic Trans-Sphenoidal Resection of Pituitary Tumors using Image-Based Vascular and Cranial Nerve Segmentation: A Prospective Validation Study
, Neuro-Oncology 16(Suppl 5): v141 (2014)

Ni-20 * Adc Histogram Analysis following Radiotherapy Predicts Response to Adjuvant Temozolomide in Newly Diagnosed Gbm
, Neuro-Oncology 16(Suppl 5): v142 (2014)

Ni-02 * Elevated Myoinositol in Diffuse Astrocytoma; a Marker of Anaplastic Phenotype, and not Attributable to Microglial Infiltration
, Neuro-Oncology 16(Suppl 5): v138 (2014)

Ni-21 * Contrast Enhanced T1 Subtraction Maps Improve Detection of Residual Tumor following Resection, Reduces Measurement Variability, and Predicts Survival after Anti-Angiogenic Therapy in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v142 (2014)

Ni-22 * Non-Enhancing Tumor Response using Quantitative T2 Maps Predicts Survival in Glioblastoma Treated with Bevacizumab
, Neuro-Oncology 16(Suppl 5): v142-v143 (2014)

Ni-23 * Brain Breast Metastases Respond to Anti-Angiogenic Therapy by Modes of Vascular Normalization
, Neuro-Oncology 16(Suppl 5): v143 (2014)

Ni-24 * Improving Biobanked Specimen Quality: Label-Free Microscopic Assessment of Human Brain Tumor Biopsies Prior to Biobanking
, Neuro-Oncology 16(Suppl 5): v143 (2014)

Ni-25 * Physiologic Imaging in Patients with Brain Metastases; Heterogeneity Based upon Primary Tumor Subtype
, Neuro-Oncology 16(Suppl 5): v143 (2014)

Ni-26 * Comparative Analysis Of The Rano And Macdonad'S Criteria In Recurrent Glioblastoma Treated In The Randomized Phase Ii Trial Avareg With Bevacizumab Or Fotemustine
, Neuro-Oncology 16(Suppl 5): v143-v144 (2014)

Ni-28 * Analysis of Bevacizumab Response to Distinguish between Tumor Recurrence and Cerebral Radiation Necrosis
, Neuro-Oncology 16(Suppl 5): v144 (2014)

Ni-29 * Diagnosis of Pseudoprogression in Patients with Glioblastoma using Amino Acid Pet
, Neuro-Oncology 16(Suppl 5): v144 (2014)

Ni-31 * using Tumor Localization Maps to Identify Brain Locations Involved in Cognitive Functioning in Glioma Patients before Therapy
, Neuro-Oncology 16(Suppl 5): v144-v145 (2014)

Ni-03 * Dsc-Mri Measures Of rCbv Predict Tumor Characteristics Beyond Standard Histopathology
, Neuro-Oncology 16(Suppl 5): v138 (2014)

Ni-33 * Third Ventricular Glioblastoma Multiforme: Case Report and Literature Review
, Neuro-Oncology 16(Suppl 5): v145 (2014)

Ni-34 * Brain Locations Involved in Cognitive Alterations after Resective Brain Surgery Identified by Resection Probability Maps
, Neuro-Oncology 16(Suppl 5): v145 (2014)

Ni-35 * Establishment of Brain Tumor Phospholipid Imaging Profiling by Maldi Mass Spectrometry - a Mouse Model
, Neuro-Oncology 16(Suppl 5): v145 (2014)

Ni-36 * Validation of Rano Criteria: Contribution of T2/Flair Assessment in Patients with Recurrent Glioblastoma Treated with Bevacizumab
, Neuro-Oncology 16(Suppl 5): v145-v146 (2014)

Ni-37 * Increased Cerebral Amino Acid Uptake During And After Epileptic Disorders Mimics Brain Tumor In 18F-Fet Pet
, Neuro-Oncology 16(Suppl 5): v146 (2014)

Ni-38 * Glioblastoma Subtypes Defined by Quantitative Imaging Map to different Canonical Signaling Pathways
, Neuro-Oncology 16(Suppl 5): v146 (2014)

Ni-39 * Initial Evaluation Of An Adenosine Receptor Agonist'S Ability To Transiently Disrupt The Blood Brain Barrier (Bbb) In Patients With In Normal Brains
, Neuro-Oncology 16(Suppl 5): v146 (2014)

Ni-40 * Mr Imaging and Spectroscopy Provides Insight into Malignant Transformation and Idh-Mutation Status in Diffuse Low-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v146-v147 (2014)

Ni-41 * Prognostic Significance Of Dynamic Analysis Of 18Fet-Pet In Newly Diagnosed High Grade Glioma
, Neuro-Oncology 16(Suppl 5): v147 (2014)

Ni-04 * Immediate Post Operative Volume of Abnormal Flair Signal Predicts Patient Survival in Glioblastoma Patients
, Neuro-Oncology 16(Suppl 5): v138 (2014)

Ni-42 * Altered Structural Connectivity in Widely Distributed Bilateral Hemispheric Networks of Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 5): v147 (2014)

Ni-43 * Growth Kinetics of Contrast Enhancing Gliomas Associate Invasive Growth with Seizure Presentation
, Neuro-Oncology 16(Suppl 5): v147 (2014)

Ni-44 * Liposomal Nanoparticles for Targeting and Imaging of Pediatric Brain Tumors
, Neuro-Oncology 16(Suppl 5): v147-v148 (2014)

Ni-45 * Kinetic Analysis of Tryptophan Pet can Estimate Histologic Grade and Proliferative Activity in Meningiomas
, Neuro-Oncology 16(Suppl 5): v148 (2014)

Ni-46 * the Impact of Integrating Volumetric Mr Spectroscopic Imaging in Radiation Treatment Planning for Glioblastoma
, Neuro-Oncology 16(Suppl 5): v148 (2014)

Ni-47 * Gliomatosis Meningi and Gliomatosis Cerebri: Kissing Cousins? Case Report and Review of the Literature
, Neuro-Oncology 16(Suppl 5): v148 (2014)

Ni-48 * Comparison Of Dti And 11C-Methionine Pet Focusing On Their Predictive Values Of Tumor Cell Density In Gliomas
, Neuro-Oncology 16(Suppl 5): v148-v149 (2014)

Ni-50 * Segmentation of Metastatic Lesions in Large-Scale Registries: Comparison of Expert Manual Segmentation Vs. Semi-Automated Methods
, Neuro-Oncology 16(Suppl 5): v149 (2014)

Ni-51 * Stereotactic Robot-Guided Biopsies of Brain Lesions: Experience with 4 Cases
, Neuro-Oncology 16(Suppl 5): v149 (2014)

Ni-05 * Immediate Post-Resection Pericavitarian Dwi Hyperintensity in Glioblastoma Patients is Predictive of Patient Outcome
, Neuro-Oncology 16(Suppl 5): v138-v139 (2014)

Ni-52 * Towards Improved Integration of Advanced Imaging Techniques into the Neurosurgical Operating Suite: A Canadian Experience
, Neuro-Oncology 16(Suppl 5): v149 (2014)

Ni-53 * Progressive Multifocal Leukoencephalopathy Mimicking high Grade Glioma in an Immunocompetent Patient: A Case Report
, Neuro-Oncology 16(Suppl 5): v149-v150 (2014)

Ni-54 * Hypervascular Volume Estimated by Comparison to a Large-Scale Cerebral Blood Volume (Cbv) Radiographic Atlas Predicts Survival in Recurrent Glioblastoma Treated with Bevacizumab
, Neuro-Oncology 16(Suppl 5): v150 (2014)

Ni-55 * Parametric Maps of Contrast Agent Diffusion using a Novel Diffusion-Perfusion Model Applied to Dce-Mri can Differentiate Non-Enhancing Tumor from Edema in Human Glioblastoma
, Neuro-Oncology 16(Suppl 5): v150 (2014)

Ni-56 * Fet-Pet Adds Predictive Value to Localization of Treatment Failure in high Grade Gliomas
, Neuro-Oncology 16(Suppl 5): v150 (2014)

Ni-57 * Dynamic Contrast-Enhanced Magnetic Resonance Perfusion Weighted Imaging (Dce-Mri) and Diffusion Weighted Imaging (Dwi) for Pharmacodynamic Evaluation of Carboxyamidotriazole Orotate (Cto) and Temozolomide in Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v150-v151 (2014)

Ni-58 * Location of Glioblastoma Intersectiing White Matter Tracts Predict Patient Prognosis and Response to Bevacizumab Prior to Therapy
, Neuro-Oncology 16(Suppl 5): v151 (2014)

Ni-59 * Tablet Technology for Improved Preoperative Speech Mapping using Functional Mri in Patients with Low-Grade Glioma
, Neuro-Oncology 16(Suppl 5): v151 (2014)

Ni-60 * Recurrent Patterns of Bevacizumab Monotherapy for Recurrent Primary Glioblastoma and Perspectives on Bevacizumab-Based Therapies
, Neuro-Oncology 16(Suppl 5): v151 (2014)

Ni-61 * Volumetric H-1 Mr Metabolic Imaging for Definition of Lesion Burden and Prediction of Outcome for Patients with Newly Diagnosed Gbm
, Neuro-Oncology 16(Suppl 5): v151-v152 (2014)

Ni-06 * Molecular Imaging Of Pineal Parenchymal Tumor By (68)Ga-Dotatoc-Pet/C
, Neuro-Oncology 16(Suppl 5): v139 (2014)

Ni-62 * Dce-Mri Discriminates between Responder and Non-Responder in Progressive high Grade Glioma Patients Undergoing Anti-Angiogenic Treatment
, Neuro-Oncology 16(Suppl 5): v152 (2014)

Ni-63 * Gliomatosis Cerebri: Diagnosis, Management and Outcomes in the Largest Series from a Single European Institution
, Neuro-Oncology 16(Suppl 5): v152 (2014)

Ni-64 * 3D-Printed Mri-Based Custom Brain Molds For Minimizing Tissue Distortion And Precisely Slicing Tissue For Co-Registration With Clinically Acquired Mri In Glioma Patients
, Neuro-Oncology 16(Suppl 5): v152 (2014)

Ni-65 * Differentiating Radiation effect and Necrosis from Glioblastoma with Dynamic Susceptibility Contrast (Dsc) Mri
, Neuro-Oncology 16(Suppl 5): v152 (2014)

Ni-66 * Color Coded Maps of White Matter Tracts: No Need for Tractography
, Neuro-Oncology 16(Suppl 5): v153 (2014)

Ni-67 * the Role of Flair Volume as a Prognosticating Factor in Patients with Glioblastoma
, Neuro-Oncology 16(Suppl 5): v153 (2014)

Ni-68 * 18F-Fdopa Pet In Treated Low-Grade Gliomas With Non-Enhancing T2 Changes On Mri Is Prognostic Of Tumor Progression And Overall Survival
, Neuro-Oncology 16(Suppl 5): v153 (2014)

Ni-69 * Utility Of 18F-Fdg Pet/Mr In Differentiation Of Recurrent High-Grade Glioma From Delayed Radiation Tissue Injury: Comparison Of Pet/Ct To Pet/Mr
, Neuro-Oncology 16(Suppl 5): v153 (2014)

Ni-70 * Stereotactic Biopsy with and without Intraoperative Mri
, Neuro-Oncology 16(Suppl 5): v153-v154 (2014)

Ni-71 * Developing Role of Advanced Mri Techniques for Diagnosis of High-Grade Glioma Relapse after Complex Oncology Treatment
, Neuro-Oncology 16(Suppl 5): v154 (2014)

Ni-07 * Magnetic Resonance Fingerprinting of Brain Tumors: Initial Clinical Results
, Neuro-Oncology 16(Suppl 5): v139 (2014)

Ni-72 * Correlation Of Volumetrical Analyses Derived From 18Fet-Pet And Mri With Outcome In Glioblastoma Patients
, Neuro-Oncology 16(Suppl 5): v154 (2014)

Ni-73 * Monitoring Of Biological Response To Bevacizumab In Malignant Glioma Patients Based On L-[methyl-11C] Methionine-Positron Emission Tomography
, Neuro-Oncology 16(Suppl 5): v154 (2014)

Ni-74 * Dynamic Contrast Enhanced (Dce) T1 Mri Perfusion Differentiates Pseudoprogression from Recurrent Glioblastoma
, Neuro-Oncology 16(Suppl 5): v154-v155 (2014)

Ni-76 * Computer Extracted Oriented Texture Features on T1-Gadolinium Mri for Distinguishing Radiation Necrosis from Recurrent Brain Tumors
, Neuro-Oncology 16(Suppl 5): v155 (2014)

Ni-77 * Surgical Treatments for Large and Giant Meningiomas: Experiences with 35 Consecutive Patients
, Neuro-Oncology 16(Suppl 5): v155 (2014)

Ni-78 * Label-Free Multiphoton Microscopy: A Novel Tool for the Imaging of Brain Tumors
, Neuro-Oncology 16(Suppl 5): v155-v156 (2014)

Ni-79 * Rapid Assessment of Lesion Volumes for Patients with Glioma using the Smartbrush Software Package
, Neuro-Oncology 16(Suppl 5): v156 (2014)

Ni-80 * Case Report: Treatment Response in Leptomeningeal Carcinomatosis from Gliomatosis Cerebri Treated with Bevacizumab (Avastin)
, Neuro-Oncology 16(Suppl 5): v156 (2014)

Ni-81 * Diffusion Mr Imaging Genomic Features Identifies Genomic Targets Involved in Invasion and Poor Prognosis
, Neuro-Oncology 16(Suppl 5): v156 (2014)

Ni-08 * Optimization of Molecular Mr Imaging of Glioma
, Neuro-Oncology 16(Suppl 5): v139 (2014)

Ni-82 * Diffusion and Conventional Mr Imaging Genomic Biomarker Signature for Egfr Mutation Identification in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v156-v157 (2014)

Ni-83 * Diffusion and Conventional Mr Imaging Genomic Biomarker Signature Predicts Idh-1 Mutation in Glioblastoma Patients
, Neuro-Oncology 16(Suppl 5): v157 (2014)

Ni-84 * Molecular Characteristics Underlying the Radiologically-Defined Volumetric Composition of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v157 (2014)

Ni-85 * Delayed Contrast Mri for Differentiating Tumor/Non-Tumor Tissues in Brain Tumor Patients - Histological Validation and Comparison with Dsc/Dce
, Neuro-Oncology 16(Suppl 5): v157 (2014)

Ni-86 * Combined Awake Brain Mapping and Low-Field Intraoperative Mri for Brain Tumor Resection
, Neuro-Oncology 16(Suppl 5): v157-v158 (2014)

Ni-09 * high Resolution Three-Dimensional Histological Reconstruction of Glioma Spheroids and Application in Research
, Neuro-Oncology 16(Suppl 5): v139-v140 (2014)

Nt-01 * Utility of Temozolomide in the Management of Anaplastic Astrocytoma: A Comparison of Survival in the Era Prior to and following Temozolomide
, Neuro-Oncology 16(Suppl 5): v159 (2014)

Nt-10 * Identification of Aurintricarboxylic Acid (Ata) as an Inhibitor of Tweak-Fn14 Signaling in Glioblastoma cells
, Neuro-Oncology 16(Suppl 5): v161 (2014)

Nt-11 * Targeting Interstitial Fluid Pressure to Reduce Tumor Growth and Increase Drug Uptake in Brain Tumors
, Neuro-Oncology 16(Suppl 5): v161 (2014)

Nt-12 * Impact of Humanized Chondroitinase Abc on Ov Therapy for Intracranial Tumors
, Neuro-Oncology 16(Suppl 5): v161 (2014)

Nt-14 * Early Experience with Trans-Sulcal Parafascicular Exoscopic Resection of Supratentorial Brain Tumors
, Neuro-Oncology 16(Suppl 5): v161 (2014)

Nt-17 * Treatment of Diffuse Intrinsic Pontine Glioma (Dipg) with an Oncolytic Measles Virus in Combination with Inhibitors of the Pi3-Kinase Pathway
, Neuro-Oncology 16(Suppl 5): v162 (2014)

Nt-18 * Phase I Clinical Trial of Oncolytic Virus Delta-24-Rgd (Dnx-2401) with Biological Endpoints: Implications for Viro-Immunotherapy
, Neuro-Oncology 16(Suppl 5): v162 (2014)

Nt-20 * Targeting Cdk4 and 6 in the Classical Subtype of Glioblastoma
, Neuro-Oncology 16(Suppl 5): v163 (2014)

Nt-21 * Preliminary Clinical Outcomes following Rapid Delivery Radiosurgery for Multiple Brain Metastases
, Neuro-Oncology 16(Suppl 5): v163 (2014)

Nt-02 * Early Treatment of Her2-Amplified Brain Tumours with Targeted Nk-92 cells and Focused Ultrasound Improves Survival
, Neuro-Oncology 16(Suppl 5): v159 (2014)

Nt-22 * Pav Treatment without Immediate Radiotherapy for Anaplastic Oligodendroglial Tumor with 1p/19q Co-Deletion
, Neuro-Oncology 16(Suppl 5): v163 (2014)

Nt-23 * Phase 1/2A Study Of Glutathione Pegylated Liposomal Doxorubicin (2B3-101) In Breast Cancer Patients With Brain Metastases (Bcbm) Or Recurrent High Grade Gliomas (Hgg)
, Neuro-Oncology 16(Suppl 5): v163 (2014)

Nt-24 * Ipilimumab and Bevacizumab in Glioblastoma
, Neuro-Oncology 16(Suppl 5): v163-v164 (2014)

Nt-25 * Early Japanese Experience With NovoTtf-100A System For Recurrent Gbm
, Neuro-Oncology 16(Suppl 5): v164 (2014)

Nt-26 * Pathology of Cases of Imaging Progression in Patients Diagnosed with Glioblastoma Who Have Been Treated with the Novocure - Ttf Device in the Ef-14 Trial
, Neuro-Oncology 16(Suppl 5): v164 (2014)

Nt-27 * Surgical Resection of Thalamic Malignant Glioma
, Neuro-Oncology 16(Suppl 5): v164 (2014)

Nt-28 * Neuroprotective effects of Bacopa Monnieri and Rosmarinus Officinalis Supercritical Co2 Extracts
, Neuro-Oncology 16(Suppl 5): v164 (2014)

Nt-29 * Upregulation Of Beta-Catenin In Patient-Derived Glioblastoma Xenografts Expressing EgfrvIii
, Neuro-Oncology 16(Suppl 5): v164-v165 (2014)

Nt-30 * Complications of Laser Interstitial Thermal Therapy in Patients with Brain Tumors
, Neuro-Oncology 16(Suppl 5): v165 (2014)